{
  "api": "2.0",
  "content": {
    "html": "<h1 id='0' style='font-size:22px'>거부반응과 면역억제제</h1>\n<h1 id='1' style='font-size:20px'>요약문</h1>\n<br><figure id='2'><img style='font-size:14px' alt=\"건강담기 수정 문의\" data-coord=\"top-left:(932,0); bottom-right:(1215,33)\" /></figure>\n<p id='3' data-category='paragraph' style='font-size:14px'>■ 등록일자 : 2020-07-22 ■ 업데이트: 2024-10-22 ■ 조회 : 14796 정보신청 88</p>\n<h1 id='4' style='font-size:20px'>요약문</h1>\n<p id='5' data-category='paragraph' style='font-size:18px'>\"이것만은 꼭 기억하세요!</p>\n<p id='6' data-category='list' style='font-size:18px'>· 장기 이식 후 면역체계가 이식된 장기를 이물질로 인식하여 공격하는 것을 '거부반응'이라고 합니다.<br>· 거부반응을 예방하려면 면역억제제 복용이 필수적이며, 환자별로 적정 약물 농도와 민감도를 정기적으로 확인하고 평생 동안 규칙적으로 복용해야<br>합니다.<br>· 면역억제제를 임의로 중단하거나 불규칙하게 복용하면 이식된 장기가 손상되어 재이식이 필요하거나 심한 경우 사망에 이를 수 있습니다.<br>· 면역억제제는 면역력을 낮침 감염이나 맘 발생 위험을 높일 수 있으므로, 정기 검진과 관리를 통해 부작용 예방과 질병의 조기발견을 위해 노력해야<br>합니다.<br>· 건강한 식습관과 규칙적인 운동을 유지하며, 고혈압, 고지혈증, 고혈당 등을 찰 관리하는 것이 만성 거부반응과 이식 후 합병증을 예방하는 데<br>중요합니다.</p>\n<h1 id='7' style='font-size:20px'>개요</h1>\n<p id='8' data-category='paragraph' style='font-size:18px'>1. 장기이 식과 면역반응</p>\n<br><p id='9' data-category='paragraph' style='font-size:18px'>장기에 식이란 환자의 장기가 망가져서 더 이상 기능을 하지 못하고 기존의 치료법으로 치료가 불가능한 딸기 질환자의 장기에 대해서, 다른 사람의 장기를<br>이식하여 대체함으로써 그 기능을 회복시키는 치료법입니다. 장기이식의 개념은 오래전부터 의학자들이 가지 고 있었지만, 수술 이후 환자의 면역체계가 이식한<br>장기를 공격해서 죽이는 '거부반응'이라는 거대한 장벽이 장기이식의 실현을 가로막고 있었습니다.</p>\n<br><p id='10' data-category='paragraph' style='font-size:18px'>우리 몸의 면역체계는 외부에서 침입한 이물질이나 병원균(병의 원인이 되는 군)에 대항하여 우리 몸을 보호하는 역할을 하는데 일반적으로 자신의 몸을 구성하는<br>물질들은 자신의 몸으로 인식하여 공격하지 않습니다. 하지만, 외부에서 들어온 물질들은 외부물질로 인식하고 이 외부물질을 공격하고 물리치게 됩니다. 이렇게<br>면역체계가 외부물질을 공격하여 나타나는 반응을 염증반응이라고 하며, 세균이나 바이레스, 곰팡이 등 다양한 병원균이 몸속에 침입하거나 상처를 낼 때<br>발생합니다. 이렇게 체내에 들어온 외부물질들이 이물질로 인식되면 백혈구가 이들을 공격하여 잡아먹습니다.</p>\n<br><p id='11' data-category='paragraph' style='font-size:18px'>따라서 장기미식 과정에서 다른 사람으로부터 장기나 조직을 받게 되는 경우, 환자의 면역체계는 장기나 조직을 이물질로 인식하여 공격하고 파괴하는 데 이를<br>'거부반응 이라고 합니다. 거부반응이 발생하면 다양한 증상이나 징후가 나타날 수 있습니다. 간을 이식받은 경우 발열, 황달, 복통이나 복수와 같은 증상으로<br>거부반응이 나타날 수 있고, 신장을 이식받은 경우 소변량의 감소, 부종이나 혈압 조절 이상과 같은 증상으로 거부반응이 나타날 수 있습니다.</p>\n<br><p id='12' data-category='paragraph' style='font-size:18px'>그러나 강력한 면역억제제를 사용하고 있는 현재에는 거부반응의 증상마나 징후를 볼 수 없는 경우가 더 흔하고, 이식 장기의 손상이 심하게 진행하기 전에는<br>증상이 없는 상태에서 장기 기능 검사의 이상으로만 나타납니다. 예를 들어, 간이식의 경우에는 혈액 중 간 기능 수치(Glutamic Oxaloacetic Transaminase,<br>GOT / Glutamic Pyruvate Transaminase, GPT/ 빌리루빈)가 이상을 보이고, 신장이식의 경우에는 혈액 속 크레아티닌 수치가 높아진 상태가 됩니다.<br>장기예식의 성공을 위해서는 이러한 거부반응을 극복하는 것이 필수인데, 환자의 면역체계가 이식된 장기를 공격하지 않도록 환자의 면역체계를 억제하는<br>면역액제제를 복용하여 장기이식 거부반응을 예방하거나 치료할 수 있습니다.</p>\n\n<br><figure id='14'><img style='font-size:14px' alt=\"외부에서 창입한 이들질과 병군을 공격하여 제거\n거부반응 원작역에서\n(면덕체계)\n전액체계\" data-coord=\"top-left:(356,1152); bottom-right:(927,1708)\" /><figcaption id='13' style='font-size:16px'>그림 거부반응과 면맥억제제)</figcaption></figure>\n<p id='15' data-category='paragraph' style='font-size:18px'>우리 몸의 면역체계가 외부 물질을 인식하고 방어하는 과정은 면역 세포와 면역 단백질이 담당하고 있습니다. 외부 물질을 자신과 다른 물질로 인식하는 과정은<br>특이적인 반응(물질들이 특정 물질에 대해서만 일으키는 반응)으로, 면역세포의 수용 제나 '항체'라고 하는 면역 단백질이 외부에서 들어온 특정 물질(창원)만을<br>특이적으로 이물질로 인식하고 이물질과 결합하여 파괴하게 됩니다.</p>\n<br><p id='16' data-category='paragraph' style='font-size:16px'>2. 면역반응의 시작</p>\n<p id='17' data-category='paragraph' style='font-size:18px'>이러한 면역세포 수용체나 항체가 이물질인 항원과 서로 특이적으로 결합하기 위해서는 결합 부위가 마치 자물쇠와 열쇠처럼 꼭 들어맞는 구조를 가져야 합니다.<br>또한, 다양한 항원과 결합하기 위해서 면역세포 수용체나 항체의 종류도 다양합니다.</p>\n<figure id='18'><img alt=\"\" data-coord=\"top-left:(1402,37); bottom-right:(1970,328)\" /></figure>\n<p id='19' data-category='paragraph' style='font-size:20px'>개요-정의</p>\n<p id='20' data-category='paragraph' style='font-size:16px'>거부반응은 수혜자의 면역체계가 이식된 장기를 외부물질로 인식하여 면역반응을 일으킴으로써 이식된 장기가 수혜자의 몸속에서 자리를 잡지 못하고 공격받는<br>반응입니다. 일반적으로 처음 이식한 장기는 수혜자의 면역세포가 이식 장기의 항원을 자기 것이 아니라고 인식하는 데까지 시간이 걸립니다. 그러나, 수혜자의<br>면역체계가 이전에 장기이식을 경험하였거나 수혈이나 출산 등으로 비슷한 항원에 노출되었다면, 기억 면역세포들과 항체들이 남아 있게 됩니다. 기억<br>면역세포들과 항체들이 경험했던 항원과 비슷한 항원을 가진 이식 장기가 들어오게 되면, 장기이식 수혜자는 보다 신속하고 강한 면역반응으로 심한 거부반응을<br>겪게 됩니다.</p>\n<figure id='21'><img style='font-size:14px' alt=\"0:00\" data-coord=\"top-left:(1374,638); bottom-right:(1996,956)\" /></figure>\n<p id='22' data-category='paragraph' style='font-size:20px'>개요-종류</p>\n<p id='23' data-category='paragraph' style='font-size:16px'>일반적으로 거부반응은 나타나는 시기에 따라 이식한 지 수 분에서 수 일내 발생하는 초급성 거부반응과 6개월 이내에 주로 발생하는 급성 거부반응, 그리고<br>수개월에서 수년이 지난 후 발생하는 만성 거부반응으로 나눌 수 있습니다. 하지만, 급성 거부반응도 6개월 이후에 나타날 수 있고, 만성 거부반응도 보다 이른<br>시간에 생길 수도 있습니다.</p>\n<br><p id='24' data-category='paragraph' style='font-size:16px'>거부반응의 정확한 분류는 앞에서 설명한 발생 시기에 따른 것이 아니고, 이식한 조직에 어떤 세포가 작용하여 어떤 면역기전(면역과정)으로 어떤 조직 변화를<br>일으켰는지에 따라 결정됩니다. 따라서, 거부반응의 기전(과정)과 상태에 따라 초급성, 급성, 만성 거부반응으로 분류하면서, T세포매개성 거부반응과 항체<br>매개성 거부반응으로 다시 세분할 수 있습니다.</p>\n<p id='25' data-category='paragraph' style='font-size:16px'>1) 초급성 거부반응</p>\n<br><p id='26' data-category='list' style='font-size:16px'>수혜자의 몸속에 기증자의 항원에 대한 항체가 이미 형성되어 있었던 경우 수혜자의 항체가 이식된 장기를 공격하여 발생하는 거부반응입니다. 매우 빠르게<br>진행하고 특별한 치료제가 없기 때문에 이식된 장기를 절제해야 하는 경우가 대부분입니다. 초급성 거부반응은 모두 항체 매개성 거부반응을 보입니다.<br>2) 급성 거부반응<br>이식 장기의 항원을 수혜자의 면역세포가 인지하면서 공격함으로써 발생하는 거부반응입니다. 급성 T세포매개성 거부반응과 급성 항체 매개성 거부반응으로<br>세분할 수 있고, 다양한 면역억제제를 사용하여 예방하거나 치료하기도 합니다.<br>3) 만성 거부반응</p>\n<p id='27' data-category='paragraph' style='font-size:16px'>반복적인 급성 거부반응 등 면역학적 원인과 허혈손상, 고혈압, 고혈당, 고지혈증 등 비면역학적 원인에 의해 이식된 장기가 서서히 망가지는 것을 의미합니다.<br>역시 만성 T세포매개성 거부반응과 만성 항체 매개성 거부반응으로 세분할 수 있습니다.</p>\n<figure id='28'><img style='font-size:14px' alt=\"0:00\" data-coord=\"top-left:(1372,1574); bottom-right:(1993,1884)\" /></figure>\n<p id='29' data-category='paragraph' style='font-size:20px'>개요-원인</p>\n<p id='30' data-category='paragraph' style='font-size:16px'>1) 조직적합성 항원에 대한 면역반응</p>\n<br><p id='31' data-category='paragraph' style='font-size:16px'>거부반응은 수혜자의 몸 안에서 기증자의 장기가 가지고 있는 항원이 '남의 것'으로 인식되어 생기는데, '조직적합성 항원'이 가장 대표적인 거부반응을 일으키는<br>항원입니다. 조직적합성 항원은 인간 염색체 6번에 존재하는 인간 백혈구 항원(Human leukocyte antigen, HLA)입니다. 수혜자와 기증자 사이에 HLA 항원이<br>일치하는 숫자가 많을수록 급성 거부반응이 적은데, 현재에는 면역억제제가 강력해져 HLA 항원의 일치도가 갖는 중요성은 과거보다는 줄어들었습니다. 수혜자의<br>혈액 내에 기증자의 HLA 항원에 반응하는 항체의 양이 이식 전부터 많을 때 초급성 거부반응을 일으킬 수 있기 때문에, 이식 전에 수혜자의 항체를 충분히<br>제거해야 합니다. 또는 HLA 항원에 대한 항체가 이식 전에는 없다가 이식 후 생성되어 급성이나 만성 항체 매개성 거부반응을 일으킬 수 있습니다.</p>\n<figure id='32'><img alt=\"\" data-coord=\"top-left:(1419,88); bottom-right:(1962,469)\" /></figure>\n<p id='33' data-category='paragraph' style='font-size:14px'>2) 혈액형 항원에 대한 면역반응</p>\n<br><p id='34' data-category='paragraph' style='font-size:14px'>적혈구 표면에 존재하는 혈액형 항원(ABO 항원)이 이식 장기 내의 혈관세포에도 존재하기 때문에 수혈 이상반응과 마찬가지로, 장기이식 거부반응을 일으킬 수<br>있습니다. 혈액형 부적합 이식의 경우, 이식 전에 항 혈액형 항체가 많이 존재하면 초급성 거부반응이 나타날 수 있습니다. 따라서 이식 전에 항체를 충분히<br>제거한 후 이식을 해야 하고, 이식 후 초기 4주 내에도 항체 수를 낮게 유지해야 급성 항체 매개성 거부반응을 예방할 수 있습니다.</p>\n<p id='35' data-category='paragraph' style='font-size:18px'>진단 및 검사</p>\n<p id='36' data-category='paragraph' style='font-size:14px'>1. 장기이식 전 검사</p>\n<br><p id='37' data-category='paragraph' style='font-size:14px'>1) 조직적합성 항원 및 항체 검사</p>\n<br><p id='38' data-category='paragraph' style='font-size:14px'>장기이식 후 거부반응을 방지하고 합병증을 예방하기 위해서 장기이식 전에 수혜자와 기증자의 조직적합성 항원을 검사해야 합니다. HLA 검사에는 HLA 항원형<br>(HLA 항원 종류)을 검사하는 것과 기증자와 수혜자 사이의 HLA 교차검사가 있습니다. HLA 항원검사 결과 수혜자와 기증자 사이에 항원이 일치하는 숫자가<br>많을수록 급성 거부반응이 적고, 이식한 장기의 생존율이 향상됩니다. 만약 가능한 기증자가 한 명뿐일 경우에는 일치하는 HLA 숫자가 적은 경우에라도 어느<br>정도의 좋은 결과를 기대할 수 있기 때문에 장기이식을 진행할 수 있습니다. HLA 교차검사는 수혜자의 혈액 내에 기증자의 HLA 항원에 반응하는 항체의 유무와<br>강도를 검사하는 것입니다. 더욱 정밀한 조직적합성 항원 및 항체 검사가 개발되어 이식 전에 초급성 거부반응의 발생 가능성을 미리 제거하고, 급성 항체 매개성<br>거부반응을 예방하는데 도움을 주고 있습니다.</p>\n<br><p id='39' data-category='paragraph' style='font-size:14px'>2) 혈액형 항원 및 항체 검사</p>\n<br><p id='40' data-category='paragraph' style='font-size:14px'>혈액형 항원(ABO 항원) 및 항 혈액형 항체 검사를 시행하여 이식 후 발생할 수 있는 초급성 거부반응을 예방하고, 항원 불일치로 인한 심각한 거부반응이나<br>합병증을 줄여야 합니다. ABO 혈액형 검사를 통해 동일한 혈액형 사이에 이식할 때는 문제가 없고, 동일하지 않더라도 수혈이 가능한 혈액형, 예를 들어 O형이<br>A형이나 B형의 수혜자에게 기증 시에는 장기이식이 가능합니다. 기증자의 혈액형이 수혈이 불가능한 부적합 혈액형일 경우에는 이식 후 초급성 거부반응이<br>일어나게 됩니다. 그러나, 최근에는 혈액형이 부적합한 경우, 항 혈액형 항체 자체와 이 항체를 생산하는 면역세포(B세포)를 제거하는 탈감작 치료를 통해<br>성공적인 장기이식이 가능하게 되었습니다.</p>\n<p id='41' data-category='paragraph' style='font-size:14px'>2. 거부반응 진단</p>\n<br><p id='42' data-category='paragraph' style='font-size:14px'>거부반응은 임상적인 소견이나 검사 소견을 통해 의심할 수 있으나, 확진은 이식한 장기에 대한 조직검사에 의해 이루어집니다. 장기이식 후에 발생한 거부반응은<br>즉각 알아차리기 힘든 경우가 많습니다. 이는 거부반응이 역반응에 의해 서서히 진행되며, 최근 사용되는 강력한 면역억제제가 거부반응의 증상을 가리기<br>때문입니다. 즉, 장기를 이식한 부위의 자연 통증 또는 눌러서 생기는 압통 같이 과거에 나타났던 전형적인 거부반응의 증상이나 징후는 최근 면역억제제의 효능<br>때문에 뚜렷이 나타나지 않는 경우가 대부분입니다. 따라서, 정기적인 관찰과 검사가 중요합니다.</p>\n<br><p id='43' data-category='paragraph' style='font-size:14px'>급성 거부반응은 일반적으로 이식 후 6개월 이내, 특히 3개월 이내에 발생하는 것이 대부분이므로 이 기간 동안에는 특히 주의해서 관찰해야 합니다. 신장이식의<br>거부반응으로는 잘 나오던 소변의 양이 줄면서 몸무게가 늘어나고, 혈압이 상승하며, 신장기능을 반영하는 혈청 크레아티닌 수치가 지난 검사보다 높아질 수<br>있습니다. 그러나, 환자들이 판단하기에 이런 변화가 초기에는 미미할 수 있어, 급성 거부반응이 점점 진행되다가 나중에 심해진 이후 발견되는 경우도 많습니다.<br>따라서, 임상 소견만으로는 거부반응을 진단할 수는 없고, 어느 정도 의심이 될 경우에는 이식된 장기에 대한 조직검사를 실시해서 이식된 장기의 조직 손상 상태,<br>공격하고 있는 면역세포의 종류와 침윤 정도 등으로 거부반응과 그 종류를 진단합니다.</p>\n<br><p id='44' data-category='paragraph' style='font-size:14px'>거부반응과 구별해야 하는 질환으로는 면역억제제 과다투여나 다른 약제에 의한 독성 장기손상, 말기장기부전을 일으켰던 원질환(기저질환) 재발, 바이러스 감염<br>등이 있습니다.</p>\n<p id='45' data-category='paragraph' style='font-size:18px'>치료</p>\n<p id='46' data-category='paragraph' style='font-size:14px'>1. 면역억제 치료</p>\n<br><p id='47' data-category='paragraph' style='font-size:14px'>1) 면역억제 치료의 중요성</p>\n<br><p id='48' data-category='list' style='font-size:14px'>면역억제제를 복용하는 경우 가장 중요한 점은 '얼마나 약물치료를 잘 지키는가' 입니다. 이에 따라 이식한 장기의 생존율이 좌우됩니다. 이식 후 초기 약물치료를<br>잘 따르던 환자가 1~2년 지나면서 약을 한두 번 먹지 않아도 별 증상에 변화가 없는 것을 경험하면 병원에 오는 것을 스스로 중단하거나 규칙적인 약물 복용을 잘<br>지키지 못하는 경우를 볼 수 있습니다. 그러나 스스로 약물치료를 중단하거나 불규칙하게 약물을 복용하면 이식 장기에 손상이 일어나고, 결국에 장기를 재이식을<br>해야 하거나 사망에 이르는 결과가 이어질 수 있습니다. 거부반응은 이식 후 언제라도 나타날 수 있기 때문에 이를 예방하기 위해서는 현재로선 평생<br>면역억제제를 복용해야 하며, 규칙적으로 약을 복용하는 것이 중요합니다.</p>\n<br><p id='49' data-category='list' style='font-size:14px'>2) 거부반응 예방을 위한 유도 및 유지 면역억제 치료<br>이식 환자들은 거부반응을 억제하기 위해 이식 직후에는 유도 면역억제 치료와 장기간의 유지 면역억제 치료를 받습니다.</p>\n<br><p id='50' data-category='paragraph' style='font-size:14px'>3) 거부반응 치료를 위한 항거부반응 면역억제 치료</p>\n<br><p id='51' data-category='paragraph' style='font-size:14px'>유지 면역억제 치료에도 불구하고 거부반응이 발생하거나, 환자가 약을 제대로 복용하지 않아 거부반응이 생긴 경우, 이를 회복시키기 위해서 추가적으로<br>강력하게 투여하는 면역억제제 치료를 항거부반응 면역억제 치료라고 합니다.</p>\n<p id='52' data-category='list' style='font-size:14px'>2. 거부반응의 예방을 위한 면역억제 치료<br>1) 유도 면역억제 치료<br>장기이식 직후 입원 기간 중, 거부반응을 억제하기 위해 바실릭시맙(시뮬렉트) 또는 다클론 항림프구 항체인 티모글로불린(에이티지) 주사제를 투여 받습니다.<br>2) 유지 면역억제 치료<br>거부반응의 발생을 예방하기 위해 2~4가지의 면역억제제를 함께 사용하여 이식 후부터 평생 동안 복용합니다.</p>\n<p id='53' data-category='list' style='font-size:14px'>3. 거부반응의 치료<br>1) 초급성 거부반응에 대한 치료<br>초급성 거부반응은 일단 발생하면 치료가 거의 불가능하기 때문에, 기증자와 수혜자 간의 항원 교차반응 검사 등으로 예방하는 것이 필수입니다.<br>2) 급성 거부반응에 대한 치료</p>\n<br><p id='54' data-category='paragraph' style='font-size:14px'>급성 거부반응 중, 급성 T세포매개성 거부반응은 급성 항체 매개성 거부반응보다 치료 반응률이 높습니다. 급성 T세포매개성 거부반응은 고용량 스테로이드<br>충격요법을 일차적으로 사용하고 반응이 없을 경우 다클론 항림프구 항체(예를 들어 티모글로불린, 에이티지(antithymocyte globulin, ATG))를 2차 치료제로<br>사용하여 치료하는데, 1차치료에 약 75%, 2차치료에 60%가 반응하여 총 약 90%의 반응률을 보입니다. 그래도 반응이 없을 경우, 유지 면역억제제를 더 강한<br>약제로 바꾸어서 치료해 보기도 합니다. 예를 들어, 사이클로스포린에서 타크로리무스로 바꾸거나, 사용하고 있지 않다면 마이코페놀레이트 계열의 약제를<br>추가하기도 합니다. 급성 항체매개성 거부반응은 T세포매개성 거부반응보다 치료 반응률이 낮은데, 혈장반출술, 리툭시맙, 보르테조밉, 고용량 면역글로불린<br>주사 등의 치료를 시도해 볼 수 있습니다.</p>\n<br><p id='55' data-category='paragraph' style='font-size:14px'>3) 만성 거부반응에 대한 치료</p>\n<br><p id='56' data-category='paragraph' style='font-size:14px'>만성 거부반응은 면역억제제를 거르거나 정확하게 복용하지 않은 경우가 중요한 원인이며, 치료에 의한 반응률이 낮습니다. 만성 거부반응에 대한 면역억제<br>치료는 기본적으로 급성 거부반응에 대한 면역억제 치료와 유사합니다. 만성 거부반응에 대한 치료에서 조직 장기의 만성 변화가 심할수록 치료 반응률이 낮기<br>때문에 만성적 섬유화 진행이 초기일 경우에는 강한 면역억제 치료도 고려하나, 만성적 섬유화 진행이 심하게 진행된 경우에는 지나치게 강한 면역억제는 치료<br>효능보다 부작용이 더 문제가 될 수 있습니다. 만성 거부반응에는 면역학적 원인 이외에도 고혈압, 고지혈증, 고혈당, 약물 독성 다양한 비면역학적 원인들도<br>기여하기 때문에 이에 대한 효과적인 조절도 중요합니다.</p>\n<p id='57' data-category='paragraph' style='font-size:18px'>치료-약물 치료</p>\n<p id='58' data-category='paragraph' style='font-size:14px'>1. 면역억제제의 종류</p>\n<br><p id='59' data-category='paragraph' style='font-size:14px'>1) 유도 면역억제제</p>\n<br><p id='60' data-category='paragraph' style='font-size:14px'>① 항흉선세포글로불린, 에이티지(티모글로불린)</p>\n<br><p id='61' data-category='paragraph' style='font-size:14px'>다클론성 항림프구 항체의 하나로서 현재 토끼에 인간 흉선 T세포를 면역하여 만들어집니다. 장기 재이식 환자나 고감작 환자 등 거부반응의 위험이 높은<br>환자들에게 수술 직후 3-5일간 주사하는 강력한 유도 치료로서 급성 거부반응을 예방합니다. 임파종이나 바이러스 감염 등 부작용의 위험이 있기 때문에<br>저위험군 환자에서는 일반적으로 사용하지 않으나 저용량으로 사용해 볼 수도 있습니다. 또한, 세포성 거부반응이 스테로이드 충격요법에 반응이 없을 경우,<br>항거부반응 치료에서 2차 약제로 5-14일간 사용해 볼 수 있습니다.</p>\n<br><p id='62' data-category='paragraph' style='font-size:14px'>② 바실릭시맙(시뮬렉트)</p>\n<br><p id='63' data-category='paragraph' style='font-size:14px'>이식 당일과 이식 후 4일째 주사하는 유도 면역억제제 치료제로서, 거부반응의 위험이 높지 않은 경우에 거부반응 예방 목적으로 사용합니다.</p>\n<p id='64' data-category='paragraph' style='font-size:14px'>2) 유지 면역억제제</p>\n<br><p id='65' data-category='paragraph' style='font-size:14px'>① 스테로이드 (프레드니솔론, 소론도, 캘코트, 프란딘)</p>\n<br><p id='66' data-category='paragraph' style='font-size:14px'>1960년대 이후 가장 오랫동안 사용되어온 면역억제제로서 급성 거부반응 치료와 면역억제 유지 요법에 광범위하게 사용되고 있습니다. 그러나, 여러가지<br>부작용이 동반되는데, 대표적인 부작용으로 속쓰림, 혈압 상승, 혈당 상승, 여드름과 피부 발적(피부가 빨간빛을 띠는 것), 부종, 골다공증 및 대퇴골 괴사증 등이<br>있습니다. 이식 후 단기간에 대량의 스테로이드가 투여되어 당뇨병, 골다공증, 소아에서 성장장애 등이 발생할 수 있으며, 약물 용량에 비례하여 다양한 부작용이<br>발생합니다. 스테로이드 치료의 심한 부작용이 발생할 경우 용량을 줄이거나 중단할 수 있는데, 이 경우 거부반응의 위험이 올라간다는 잠재적인 문제점도<br>있습니다. 특히, 거부반응의 위험이 높은 이식 환자의 경우 스테로이드를 줄이거나 중단할 경우 급성 거부반응의 위험이 높아지기 때문에, 담당의사와 충분한<br>상의 후에 스테로이드 용량 조절을 하는 것이 바람직합니다.</p>\n<p id='67' data-category='paragraph' style='font-size:14px'>② 칼시뉴린 억제제 계열의 약물</p>\n<br><p id='68' data-category='paragraph' style='font-size:14px'>• 사이클로스포린(산디문뉴오랄, 사이폴-엔)</p>\n<br><p id='69' data-category='paragraph' style='font-size:14px'>1980년대 초부터 신장이식에 사용된 사이클로스포린은 강력한 면역억제제로 이식 후의 거부반응을 예방하기 위해 사용합니다. 사이클로스포린은 식사와<br>관계없이 12시간 간격으로 일정하게 하루에 두 번 복용합니다. 경구용 캡슐제의 용량은 100 mg과 25 mg의 2가지 용량이 있으므로 처방받은 약의 용량을<br>정확히 알고 복용해야 합니다. 시럽제를 복용할 때는 우유, 오렌지 주스와 같은 음료에 섞어서 복용할 수 있으며, 자몽주스는 이 약의 흡수에 영향을 끼치므로<br>피하거나 4시간 이상 간격을 두어야 합니다. 시럽을 음료수와 함께 유리컵에 넣고 금속으로 된 숟가락으로 저어 섞은 다음 바로 마시고, 한번 더 음료수를 넣고<br>유리컵을 흔들어 준 후 마십니다. 이 때 플라스틱 용기를 사용하면 약효가 떨어지므로 사용하지 않도록 합니다. 대표적인 부작용으로는 신장기능 저하, 혈압상승,<br>두통, 고지혈증, 구토, 다모증, 잇몸 증식, 혈당상승, 감염, 열감 등이 있습니다. 용량과 비례해서 부작용이 늘어나기 때문에 반드시 약물 복용 직전의 최저<br>약물농도를 측정해 가면서 목표 농도 내에서 사용하는 것이 중요합니다.</p>\n<br><p id='70' data-category='paragraph' style='font-size:14px'>• 타크로리무스(프로그랍, 타크로벨, 아드바그랍)</p>\n<br><p id='71' data-category='paragraph' style='font-size:14px'>타크로리무스는 사이클로스포린과 유사하게 작용하여 장기이식 후 거부반응을 억제하는 목적으로 사용하는 약으로, 사이클로스포린의 10~100배의 효능을<br>가진다고 알려져 있습니다. 음식과 함께 복용할 경우 약물의 흡수에 방해가 되므로, 반드시 공복(배 속이 비어 있는 상태) 상태에서 복용해야 합니다. 12시간<br>간격으로 하루 2번, 복용 시간은 식사하기 1시간 전 또는 식사 후 2시간이 좋습니다. 최근에는 12시간 간격으로 먹던 프로그라프를 하루 1회 복용으로<br>약물농도를 유지할 수 있는 '아드바그랍' 이라는 서방형 약제(체내에서 천천히 효과가 방출되는 약제)를 사용할 수 있습니다. 대표적인 부작용으로는 신장기능<br>저하, 혈압 상승, 혈당 상승, 손떨림, 탈모 등이 있습니다. 초기 고용량 투여 때 구토, 두통, 손떨림 등이 나타날 수 있으나 점차 감소되며, 긴 기간 동안 복용할 경우<br>탈모가 나타날 수 있습니다. 사이클로스포린과 유사한 부작용을 보이나 특별히 신경독성, 당뇨병, 탈모증이 더 많이 생기는 것으로 알려져 있습니다.</p>\n<p id='72' data-category='paragraph' style='font-size:14px'>③ 마이코페놀릭산(셀셉트, 마이렙트, 마이폴틱)</p>\n<br><p id='73' data-category='paragraph' style='font-size:14px'>마이코페놀릭산은 단독으로 사용되기보다는 다른 면역억제제에 추가하여 사용됩니다. 마이코페놀릭산을 추가하여 같이 투여할 경우, 다른 면역억제제를 적게<br>사용해도 같은 효과를 볼 수 있어 면역억제제로 인한 신장 독성을 줄일 수 있습니다. 비슷한 계열의 약제인 아자치오프린이 모든 세포에 비선택적으로 작용하는데<br>반해 마이코페노릭산은 선택적이라는 장점이 있습니다. 하루 2번 아침, 저녁으로 복용하며, 캡슐과 장용정(위산에 강한 성분을 넣어 장에서 소화되게 하는 약제)<br>2가지 제형이 있습니다. 장용정의 경우 용량에 따라 약의 모양이 다르므로 처방받은 약의 용량을 정확히 알고 복용해야 합니다. 마이코페놀릭산은 빈 속에<br>복용하는 것이 약물 흡수를 위해 권장되지만, 위장장애가 있는 경우에는 식사 후에 복용할 수 있습니다. 부작용으로 설사, 구토, 식욕부진과 같은 위장 장애가<br>흔하며, 빈혈, 백혈구감소증, 혈소판감소증과 같은 골수 억제 효과가 나타날 수 있습니다. 그리고 바이러스 감염을 증가시킵니다. 최근에 셀셉트의 위장장애를<br>개선하기 위해 장내에서 흡수되도록 만든 마이폴틱이 시중에 판매되어 사용되고 있습니다.</p>\n<p id='74' data-category='paragraph' style='font-size:14px'>④ 엠토르 억제제: 시롤리무스(라파뮨), 에베로리무스(써티칸)</p>\n<br><p id='75' data-category='paragraph' style='font-size:14px'>이 계열의 면역억제제들은 타크로리무스와 같은 칼시뉴린 억제제보다 종양 발생이 적은 것으로 알려져 있어 종양의 병력이 있던 환자에서 예방적으로 쓰거나,<br>이식 후 발생한 종양에서 치료적으로도 사용할 수 있습니다. 시롤리무스는 1일 1회, 에베로리무스는 1일 2회 복용합니다. 식사와 관계없이 일정 시간에 복용이<br>가능하고, 시롤리무스는 사이클로스포린과 함께 사용하는 경우 사이클로스포린을 복용하고 4시간이 지난 이후에 복용합니다. 자몽이나 자몽 주스와 함께<br>복용하는 것은 금하며, 다음 약 복용하기 직전 최저 혈액 내 약물 농도를 측정하여 약물용량을 조절합니다. 대표적인 부작용으로 감염 위험이 증가하는 것과<br>고지혈증, 고혈압 발생이 증가할 수 있습니다. 칼시뉴린 억제제보다는 덜하지만 당뇨병과 신독성도 나타날 수 있습니다. 또한 수술초기 상처치유가 늦어지는<br>부작용이 나타날 수 있습니다.</p>\n<p id='76' data-category='paragraph' style='font-size:14px'>⑤ 기타 약제: 미조리빈(브레디닌), 아자치오프린(이뮤란)</p>\n<br><p id='77' data-category='paragraph' style='font-size:14px'>미조리빈은 마이코페놀릭산 계열의 약제와 유사한 효능을 가지고 있고, 하루 100 ml를 두 번 복용하나 신장 기능이 감소될 경우 용량을 줄여야 합니다.<br>아자치오프린은 주로 다른 면역억제제에 추가하여 사용되는데, 하루에 1번 아침 또는 저녁 식사 후 30분에 복용합니다. 골수 억제작용 때문에 백혈구 숫자가<br>감소하고 빈혈이나 혈소판 감소도 함께 나타납니다. 그 외에도 위장장애와 간염에 의한 황달과 같은 부작용이 나타날 수 있습니다.</p>\n<p id='78' data-category='paragraph' style='font-size:14px'>2. 면역억제제 치료의 원칙</p>\n<br><p id='79' data-category='list' style='font-size:14px'>면역억제제 치료의 원칙은 환자가 효과를 최대로 유지하면서 부작용은 최소화할 수 있는 최적 용량을 유지하는 것으로, 칼시뉴린 억제제나 엠토르 억제제의<br>경우에는 최적 농도를 유지하는 것이 중요합니다.<br>면역억제제 치료에서 유의해야 할 점은, 환자마다 동일한 용량의 면역억제제를 복용하더라도 약물 흡수나 분해가 틀리기 때문에 혈액 내 농도가 틀릴 수 있고,<br>심지어 같은 혈액 내 약물 농도에 대해서도 환자가 보이는 면역억제 효과나 부작용에 대한 민감도가 틀립니다. 따라서 환자 개인마다 약물 농도를 정기적으로<br>확인해야 하고, 환자의 면역억제제에 대한 민감도를 개인별로 평가하는 것이 필요합니다.</p>\n<p id='80' data-category='paragraph' style='font-size:16px'>이식 후 면역억제제로 인해 다양한 부작용이 발생할 수 있습니다. 면역억제제는 미생물이나 암에 대한 우리 몸의 면역력을 낮춰 결과적으로 암의 성장을 돕거나<br>감염이 쉽게 발생할 수 있으며, 신장이나 간독성을 나타낼 수도 있습니다. 따라서 이런 면역억제제로 인한 부작용을 줄이기 위해서는 가능한 적은 유지용량으로<br>약물을 복용하도록 조절하는 것이 중요하지만, 너무 적게 먹을 경우 목표 농도보다 낮아져서 거부반응이 발생한다는 문제점도 고려하여 무조건 적은 용량보다는<br>적정한 용량을 복용하는 것이 중요합니다.</p>\n<br><p id='81' data-category='paragraph' style='font-size:16px'>일반적으로 이식 후 6개월 정도까지는 초기에 흔히 발생하는 급성 거부반응을 예방하기 위해서 각종 면역억제제를 고용량으로 사용하지만, 이후 서서히 양을<br>줄여 나가게 됩니다. 현재 면역억제 치료는 다른 기전으로 작용하는 2~3가지 다른 면역억제제들을 동시에 사용하는 병용요법이 가장 흔합니다. 이렇게 여러 개의<br>다른 면역억제제를 병용하는 이유는, 첫째, 한 개의 약제만으로는 충분히 모든 면역 과정을 차단시킬 수 없다는 점이고, 둘째, 병용요법을 하면 각각의 약제<br>투여량은 줄어들어서 부작용은 감소하지만, 약의 효과는 증가시킬 수 있기 때문입니다. 과거에는 스테로이드와 아자치오프린(azathioprine) 두 가지 약제를 함께<br>사용하는 2제 병용요법를 했지만, 지금은 칼시뉴린 억제제 계열의 약제들 중 한 개(타크로리무스 또는 사이클로스포린)와 마이코페노릭산(셀셉트, 마이폴틱),<br>그리고 스테로이드를 함께 사용하는 3자 병용요법을 널리 사용하고 있습니다. 또한, 시롤리무스 또는 에베로리무스를 마이코페노릭산 계열의 약제나 칼시뉴린<br>억제제를 대체해서 사용한 3제 요법이 이용되기도 합니다. 이런 기본 면역억제 치료에서, 거부반응이나 약제의 부작용이 발생할 경우, 약제를 교체해 볼 수<br>있습니다.</p>\n<p id='82' data-category='paragraph' style='font-size:16px'>3. 면역억제제 치료 경과 관찰</p>\n<br><p id='83' data-category='paragraph' style='font-size:16px'>장기이식을 받은 경우 면역억제제를 복용하면서 정기적으로 병원을 방문하여 약물의 혈중농도를 측정하기 위해 채혈을 하고, 그 결과에 따라 약물용량 조절을<br>하면서 평생 치료를 지속해야 합니다. 혹시라도 약물치료 중 약물복용을 잊었을 때는 생각났을 때 일단 빨리 약을 복용하지만 한꺼번에 2회 용량을 복용해서는 안<br>된다는 것을 기억해야 합니다.</p>\n<br><p id='84' data-category='paragraph' style='font-size:16px'>한편 면역억제제로 인해 감염에 대한 방어기능이 약화되기 때문에 정상인보다 쉽게 세균이나 바이러스, 곰팡이에 의한 감염이 나타날 수 있습니다. 따라서<br>고열이나 기침, 인후통과 같은 호흡기 감염 증상이나 자주 소변을 보거나 배뇨 시 불편감, 잔뇨감과 같이 감염을 의심할 만한 증상이 나타나면 의료진을 방문하여<br>상의해야 합니다.</p>\n<br><p id='85' data-category='paragraph' style='font-size:16px'>그리고 규칙적으로 암, 혈압, 혈당, 고지혈증, 골다공증 등 합병증에 대한 평가를 통해 면역억제제로 인한 부작용 예방 및 조기발견에 노력해야 합니다.</p>\n<p id='86' data-category='paragraph' style='font-size:22px'>치료-비약물 치료</p>\n<p id='87' data-category='paragraph' style='font-size:16px'>만성 거부반응에는 면역학적 기전 이외에도 비면역학적 기전도 존재합니다. 오늘날 생존 기간이 긴 장기이식 환자의 합병증을 줄이기 위해서 약물 치료 이외에<br>생활습관 교정과 관리도 필요합니다. 따라서, 식사와 운동, 생활습관 관리를 통해 고혈압, 고지혈증, 고혈당, 비만을 관리하는 것이 만성 거부반응과 이식 후<br>합병증을 줄이는데 중요합니다.</p>\n<p id='88' data-category='paragraph' style='font-size:22px'>예방</p>\n<p id='89' data-category='paragraph' style='font-size:16px'>거부반응을 예방하기 위해서는 이식 전 기증자와 수혜자의 교차 검사를 통해 기증자의 주조직적합성 항원을 공격하는 항체를 피해야 하고, 기증자가 여러 명이<br>있을 경우 수혜자의 주조직적합성 항원과 가장 잘 맞는 사람을 선택하는 것이 좋습니다. 이식 후에는 면역억제제의 최적 농도가 유지될 수 있도록 면역억제제를<br>규칙적이고 정확하게 복용함으로써 적절한 면역억제 상태를 유지하는 것이 거부반응 예방에 가장 중요합니다.</p>\n<p id='90' data-category='paragraph' style='font-size:22px'>자가 관리</p>\n<p id='91' data-category='paragraph' style='font-size:16px'>오늘날 급성 거부반응이 효과적으로 조절되면서 장기이식의 성적은 크게 향상되어 신장이식의 경우 평균적으로 이식된 신장의 기능이 20년 이상 유지되고<br>있습니다. 따라서, 이식 환자가 장기 생존함에 따라 면역억제제의 만성 합병증이나 기저질환으로 인한 만성 합병증을 잘 관리하는 것이 생존 기간 연장과 삶의 질<br>향상에 중요합니다. 암이나 심장병, 당뇨병, 고지혈증, 근골격계 합병증 등 다양한 합병증에 대한 환자 자신의 생활습관 교정과 정기적인 건강검진이 필요합니다.</p>\n<p id='92' data-category='paragraph' style='font-size:22px'>자주하는 질문</p>\n<p id='93' data-category='paragraph' style='font-size:20px'>Q. 면역억제제 중 가장 많이 사용하는 사이클로스포린과 병용했을 때 사이클로스포린의 약물농도를 증량하거나 감량하나요?</p>\n<br><p id='94' data-category='paragraph' style='font-size:16px'>A.</p>\n<br><p id='95' data-category='paragraph' style='font-size:16px'>사이클로스포린의 약물농도를 낮추는 약제 중에는 딜란틴(dilantin), 페노바비탈(phenobarbital), 테그레톨(tegretol), 리팜핌(rifampin) 등이 있고, 높이는<br>약제에는 베라파밀(verapamil), 딜티아젬(diltiazem), 케토코나졸(ketoconazole), 에리스로마이신(erythromycin), 시메타딘(cimetidine), 암포테리신<br>B(amphotericin B) 등이 있습니다. 이들 대부분이 면역억제 치료 중에 사용 가능한 약제이기 때문에 상호작용을 감안해서 약을 증량 또는 감량해서<br>사용해야 합니다.</p>\n<p id='96' data-category='paragraph' style='font-size:20px'>Q. 장기이식 시, 골수이식을 같이 한다는 말은 무엇을 의미합니까?</p>\n<br><p id='97' data-category='paragraph' style='font-size:16px'>A.</p>\n<br><p id='98' data-category='paragraph' style='font-size:16px'>장기이식을 해서 이식조직의 항원이 몸 속에 들어와도 깨닫지 못하는 수혜자가 있는데 이런 경우는 서로 다른 조직들이 한 몸 속에 공존하며 살아가는<br>것입니다. 이런 상황을 면역치료에 이용하기 위해 장기이식 전에 기증자의 골수를 수혜자에게 이식하여 수혜자 몸 안의 면역세포들이 이후 이식된 장기의<br>항원을 남의 것으로 인식하지 못하게 하는 것입니다.</p>\n<p id='99' data-category='paragraph' style='font-size:20px'>Q. 향후 면역 치료의 방향은 어떤 것들이 있나요?</p>\n<br><p id='100' data-category='paragraph' style='font-size:16px'>A.</p>\n<br><p id='101' data-category='paragraph' style='font-size:16px'>면역치료의 목적은 이식 장기의 항원을 인식하지 못하게 하도록 면역 체계를 억제하는 것입니다. 따라서 이상적으로는 수혜자가 기증조직에 대해 내성을<br>갖게 해주는 면역관용 상태를 만들거나, 외부 이식 항원에 반응을 하지 않도록 해주는 면역 무반응 상태를 만들어 주는 것입니다. 기증자의 항원을<br>반복적으로 수혜자에게 노출시켜서 자기 것인 것처럼 인식하게 해주는 탈감작법, 기증자의 골수세포를 함께 이식해주어 수혜자 체내에 기증자와 수혜자<br>면역세포가 공존하게 하여 기증자의 항원을 인지하지 못하게 하는 방법, 기증자의 T세포를 모두 파괴시키는 방법 등의 이론적인 방법은 가능하고 일부는<br>임상 적용 중에 있습니다.</p>\n<p id='102' data-category='paragraph' style='font-size:18px'>본 공공저작물은 공공누리 \"출처표시+상업적이용금지+변경금지\" 조건에 따라 이용할 수 있<br>습니다.</p>\n<p id='103' data-category='paragraph' style='font-size:14px'> 목록</p>\n<br><header id='104' style='font-size:18px'>개인정보처리방침 개인정보이용안내 저작권정책 및 웹접근성</header>\n<p id='105' data-category='list' style='font-size:18px'>[ 28159 ] 충청북도 청주시 흥덕구 오송읍 오송생명2로 187 오송보건의료행정타운 내 질병관리청<br>문의사항: 02-2030-6602 (평일 9:00-17:00, 12:00-13:00 제외) / 관리자 이메일 : nhis@korea.kr</p>\n<br><p id='106' data-category='paragraph' style='font-size:14px'>COPYRIGHT @ 2024 질병관리청. ALL RIGHT RESERVED</p>\n<p id='107' data-category='paragraph' style='font-size:18px'>※ 본 페이지에서 제공하는 내용은 참고사항일 뿐 게시물에 대한 법적책임은 없음을 밝혀드립니다. 자세한 내용은 전문가와 상담하시기 바랍니다.</p>\n<br><p id='108' data-category='paragraph' style='font-size:18px'>해외기관  유관기관  정부기관 </p>\n<figure id='109'><img alt=\"\" data-coord=\"top-left:(2150,140); bottom-right:(2260,224)\" /></figure>",
    "markdown": "",
    "text": ""
  },
  "elements": [
    {
      "category": "heading1",
      "content": {
        "html": "<h1 id='0' style='font-size:22px'>거부반응과 면역억제제</h1>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0337,
          "y": 0.014
        },
        {
          "x": 0.1774,
          "y": 0.014
        },
        {
          "x": 0.1774,
          "y": 0.0317
        },
        {
          "x": 0.0337,
          "y": 0.0317
        }
      ],
      "id": 0,
      "page": 1
    },
    {
      "category": "heading1",
      "content": {
        "html": "<h1 id='1' style='font-size:20px'>요약문</h1>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0358,
          "y": 0.0455
        },
        {
          "x": 0.0691,
          "y": 0.0455
        },
        {
          "x": 0.0691,
          "y": 0.0601
        },
        {
          "x": 0.0358,
          "y": 0.0601
        }
      ],
      "id": 1,
      "page": 1
    },
    {
      "base64_encoding": "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",
      "category": "figure",
      "content": {
        "html": "<br><figure id='2'><img style='font-size:14px' alt=\"건강담기 수정 문의\" data-coord=\"top-left:(932,0); bottom-right:(1215,33)\" /></figure>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.4762,
          "y": 0.0003
        },
        {
          "x": 0.6207,
          "y": 0.0003
        },
        {
          "x": 0.6207,
          "y": 0.0158
        },
        {
          "x": 0.4762,
          "y": 0.0158
        }
      ],
      "id": 2,
      "page": 1
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='3' data-category='paragraph' style='font-size:14px'>■ 등록일자 : 2020-07-22 ■ 업데이트: 2024-10-22 ■ 조회 : 14796 정보신청 88</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0376,
          "y": 0.0708
        },
        {
          "x": 0.365,
          "y": 0.0708
        },
        {
          "x": 0.365,
          "y": 0.0853
        },
        {
          "x": 0.0376,
          "y": 0.0853
        }
      ],
      "id": 3,
      "page": 1
    },
    {
      "category": "heading1",
      "content": {
        "html": "<h1 id='4' style='font-size:20px'>요약문</h1>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.034,
          "y": 0.1003
        },
        {
          "x": 0.0717,
          "y": 0.1003
        },
        {
          "x": 0.0717,
          "y": 0.1146
        },
        {
          "x": 0.034,
          "y": 0.1146
        }
      ],
      "id": 4,
      "page": 1
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='5' data-category='paragraph' style='font-size:18px'>\"이것만은 꼭 기억하세요!</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0509,
          "y": 0.139
        },
        {
          "x": 0.1436,
          "y": 0.139
        },
        {
          "x": 0.1436,
          "y": 0.151
        },
        {
          "x": 0.0509,
          "y": 0.151
        }
      ],
      "id": 5,
      "page": 1
    },
    {
      "category": "list",
      "content": {
        "html": "<p id='6' data-category='list' style='font-size:18px'>· 장기 이식 후 면역체계가 이식된 장기를 이물질로 인식하여 공격하는 것을 '거부반응'이라고 합니다.<br>· 거부반응을 예방하려면 면역억제제 복용이 필수적이며, 환자별로 적정 약물 농도와 민감도를 정기적으로 확인하고 평생 동안 규칙적으로 복용해야<br>합니다.<br>· 면역억제제를 임의로 중단하거나 불규칙하게 복용하면 이식된 장기가 손상되어 재이식이 필요하거나 심한 경우 사망에 이를 수 있습니다.<br>· 면역억제제는 면역력을 낮침 감염이나 맘 발생 위험을 높일 수 있으므로, 정기 검진과 관리를 통해 부작용 예방과 질병의 조기발견을 위해 노력해야<br>합니다.<br>· 건강한 식습관과 규칙적인 운동을 유지하며, 고혈압, 고지혈증, 고혈당 등을 찰 관리하는 것이 만성 거부반응과 이식 후 합병증을 예방하는 데<br>중요합니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0501,
          "y": 0.1577
        },
        {
          "x": 0.598,
          "y": 0.1577
        },
        {
          "x": 0.598,
          "y": 0.2494
        },
        {
          "x": 0.0501,
          "y": 0.2494
        }
      ],
      "id": 6,
      "page": 1
    },
    {
      "category": "heading1",
      "content": {
        "html": "<h1 id='7' style='font-size:20px'>개요</h1>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0337,
          "y": 0.2836
        },
        {
          "x": 0.06,
          "y": 0.2836
        },
        {
          "x": 0.06,
          "y": 0.2988
        },
        {
          "x": 0.0337,
          "y": 0.2988
        }
      ],
      "id": 7,
      "page": 1
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='8' data-category='paragraph' style='font-size:18px'>1. 장기이 식과 면역반응</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0352,
          "y": 0.3066
        },
        {
          "x": 0.1227,
          "y": 0.3066
        },
        {
          "x": 0.1227,
          "y": 0.3186
        },
        {
          "x": 0.0352,
          "y": 0.3186
        }
      ],
      "id": 8,
      "page": 1
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='9' data-category='paragraph' style='font-size:18px'>장기에 식이란 환자의 장기가 망가져서 더 이상 기능을 하지 못하고 기존의 치료법으로 치료가 불가능한 딸기 질환자의 장기에 대해서, 다른 사람의 장기를<br>이식하여 대체함으로써 그 기능을 회복시키는 치료법입니다. 장기이식의 개념은 오래전부터 의학자들이 가지 고 있었지만, 수술 이후 환자의 면역체계가 이식한<br>장기를 공격해서 죽이는 '거부반응'이라는 거대한 장벽이 장기이식의 실현을 가로막고 있었습니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0326,
          "y": 0.3233
        },
        {
          "x": 0.6215,
          "y": 0.3233
        },
        {
          "x": 0.6215,
          "y": 0.3588
        },
        {
          "x": 0.0326,
          "y": 0.3588
        }
      ],
      "id": 9,
      "page": 1
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='10' data-category='paragraph' style='font-size:18px'>우리 몸의 면역체계는 외부에서 침입한 이물질이나 병원균(병의 원인이 되는 군)에 대항하여 우리 몸을 보호하는 역할을 하는데 일반적으로 자신의 몸을 구성하는<br>물질들은 자신의 몸으로 인식하여 공격하지 않습니다. 하지만, 외부에서 들어온 물질들은 외부물질로 인식하고 이 외부물질을 공격하고 물리치게 됩니다. 이렇게<br>면역체계가 외부물질을 공격하여 나타나는 반응을 염증반응이라고 하며, 세균이나 바이레스, 곰팡이 등 다양한 병원균이 몸속에 침입하거나 상처를 낼 때<br>발생합니다. 이렇게 체내에 들어온 외부물질들이 이물질로 인식되면 백혈구가 이들을 공격하여 잡아먹습니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0317,
          "y": 0.3628
        },
        {
          "x": 0.6222,
          "y": 0.3628
        },
        {
          "x": 0.6222,
          "y": 0.4103
        },
        {
          "x": 0.0317,
          "y": 0.4103
        }
      ],
      "id": 10,
      "page": 1
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='11' data-category='paragraph' style='font-size:18px'>따라서 장기미식 과정에서 다른 사람으로부터 장기나 조직을 받게 되는 경우, 환자의 면역체계는 장기나 조직을 이물질로 인식하여 공격하고 파괴하는 데 이를<br>'거부반응 이라고 합니다. 거부반응이 발생하면 다양한 증상이나 징후가 나타날 수 있습니다. 간을 이식받은 경우 발열, 황달, 복통이나 복수와 같은 증상으로<br>거부반응이 나타날 수 있고, 신장을 이식받은 경우 소변량의 감소, 부종이나 혈압 조절 이상과 같은 증상으로 거부반응이 나타날 수 있습니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0321,
          "y": 0.4143
        },
        {
          "x": 0.6212,
          "y": 0.4143
        },
        {
          "x": 0.6212,
          "y": 0.4503
        },
        {
          "x": 0.0321,
          "y": 0.4503
        }
      ],
      "id": 11,
      "page": 1
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='12' data-category='paragraph' style='font-size:18px'>그러나 강력한 면역억제제를 사용하고 있는 현재에는 거부반응의 증상마나 징후를 볼 수 없는 경우가 더 흔하고, 이식 장기의 손상이 심하게 진행하기 전에는<br>증상이 없는 상태에서 장기 기능 검사의 이상으로만 나타납니다. 예를 들어, 간이식의 경우에는 혈액 중 간 기능 수치(Glutamic Oxaloacetic Transaminase,<br>GOT / Glutamic Pyruvate Transaminase, GPT/ 빌리루빈)가 이상을 보이고, 신장이식의 경우에는 혈액 속 크레아티닌 수치가 높아진 상태가 됩니다.<br>장기예식의 성공을 위해서는 이러한 거부반응을 극복하는 것이 필수인데, 환자의 면역체계가 이식된 장기를 공격하지 않도록 환자의 면역체계를 억제하는<br>면역액제제를 복용하여 장기이식 거부반응을 예방하거나 치료할 수 있습니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0323,
          "y": 0.4537
        },
        {
          "x": 0.6218,
          "y": 0.4537
        },
        {
          "x": 0.6218,
          "y": 0.5141
        },
        {
          "x": 0.0323,
          "y": 0.5141
        }
      ],
      "id": 12,
      "page": 1
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='13' data-category='paragraph' style='font-size:16px'>그림 거부반응과 면맥억제제)</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.2743,
          "y": 0.5226
        },
        {
          "x": 0.3796,
          "y": 0.5226
        },
        {
          "x": 0.3796,
          "y": 0.5349
        },
        {
          "x": 0.2743,
          "y": 0.5349
        }
      ],
      "id": 13,
      "page": 1
    },
    {
      "base64_encoding": "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",
      "category": "figure",
      "content": {
        "html": "<br><figure id='14'><img style='font-size:14px' alt=\"외부에서 창입한 이들질과 병군을 공격하여 제거\n거부반응 원작역에서\n(면덕체계)\n전액체계\" data-coord=\"top-left:(356,1152); bottom-right:(927,1708)\" /></figure>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.182,
          "y": 0.5389
        },
        {
          "x": 0.4735,
          "y": 0.5389
        },
        {
          "x": 0.4735,
          "y": 0.7991
        },
        {
          "x": 0.182,
          "y": 0.7991
        }
      ],
      "id": 14,
      "page": 1
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='15' data-category='paragraph' style='font-size:18px'>우리 몸의 면역체계가 외부 물질을 인식하고 방어하는 과정은 면역 세포와 면역 단백질이 담당하고 있습니다. 외부 물질을 자신과 다른 물질로 인식하는 과정은<br>특이적인 반응(물질들이 특정 물질에 대해서만 일으키는 반응)으로, 면역세포의 수용 제나 '항체'라고 하는 면역 단백질이 외부에서 들어온 특정 물질(창원)만을<br>특이적으로 이물질로 인식하고 이물질과 결합하여 파괴하게 됩니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0304,
          "y": 0.8568
        },
        {
          "x": 0.6212,
          "y": 0.8568
        },
        {
          "x": 0.6212,
          "y": 0.8931
        },
        {
          "x": 0.0304,
          "y": 0.8931
        }
      ],
      "id": 15,
      "page": 1
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='16' data-category='paragraph' style='font-size:16px'>2. 면역반응의 시작</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0319,
          "y": 0.8413
        },
        {
          "x": 0.1066,
          "y": 0.8413
        },
        {
          "x": 0.1066,
          "y": 0.8517
        },
        {
          "x": 0.0319,
          "y": 0.8517
        }
      ],
      "id": 16,
      "page": 1
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='17' data-category='paragraph' style='font-size:18px'>이러한 면역세포 수용체나 항체가 이물질인 항원과 서로 특이적으로 결합하기 위해서는 결합 부위가 마치 자물쇠와 열쇠처럼 꼭 들어맞는 구조를 가져야 합니다.<br>또한, 다양한 항원과 결합하기 위해서 면역세포 수용체나 항체의 종류도 다양합니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.0323,
          "y": 0.8973
        },
        {
          "x": 0.6213,
          "y": 0.8973
        },
        {
          "x": 0.6213,
          "y": 0.9215
        },
        {
          "x": 0.0323,
          "y": 0.9215
        }
      ],
      "id": 17,
      "page": 1
    },
    {
      "base64_encoding": "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",
      "category": "figure",
      "content": {
        "html": "<figure id='18'><img alt=\"\" data-coord=\"top-left:(1402,37); bottom-right:(1970,328)\" /></figure>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.4674,
          "y": 0.0161
        },
        {
          "x": 0.6568,
          "y": 0.0161
        },
        {
          "x": 0.6568,
          "y": 0.1402
        },
        {
          "x": 0.4674,
          "y": 0.1402
        }
      ],
      "id": 18,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='19' data-category='paragraph' style='font-size:20px'>개요-정의</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3693,
          "y": 0.1796
        },
        {
          "x": 0.4051,
          "y": 0.1796
        },
        {
          "x": 0.4051,
          "y": 0.1936
        },
        {
          "x": 0.3693,
          "y": 0.1936
        }
      ],
      "id": 19,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='20' data-category='paragraph' style='font-size:16px'>거부반응은 수혜자의 면역체계가 이식된 장기를 외부물질로 인식하여 면역반응을 일으킴으로써 이식된 장기가 수혜자의 몸속에서 자리를 잡지 못하고 공격받는<br>반응입니다. 일반적으로 처음 이식한 장기는 수혜자의 면역세포가 이식 장기의 항원을 자기 것이 아니라고 인식하는 데까지 시간이 걸립니다. 그러나, 수혜자의<br>면역체계가 이전에 장기이식을 경험하였거나 수혈이나 출산 등으로 비슷한 항원에 노출되었다면, 기억 면역세포들과 항체들이 남아 있게 됩니다. 기억<br>면역세포들과 항체들이 경험했던 항원과 비슷한 항원을 가진 이식 장기가 들어오게 되면, 장기이식 수혜자는 보다 신속하고 강한 면역반응으로 심한 거부반응을<br>겪게 됩니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.368,
          "y": 0.2009
        },
        {
          "x": 0.7528,
          "y": 0.2009
        },
        {
          "x": 0.7528,
          "y": 0.2542
        },
        {
          "x": 0.368,
          "y": 0.2542
        }
      ],
      "id": 20,
      "page": 2
    },
    {
      "base64_encoding": "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",
      "category": "figure",
      "content": {
        "html": "<figure id='21'><img style='font-size:14px' alt=\"0:00\" data-coord=\"top-left:(1374,638); bottom-right:(1996,956)\" /></figure>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.458,
          "y": 0.2726
        },
        {
          "x": 0.6654,
          "y": 0.2726
        },
        {
          "x": 0.6654,
          "y": 0.4081
        },
        {
          "x": 0.458,
          "y": 0.4081
        }
      ],
      "id": 21,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='22' data-category='paragraph' style='font-size:20px'>개요-종류</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3687,
          "y": 0.4251
        },
        {
          "x": 0.4047,
          "y": 0.4251
        },
        {
          "x": 0.4047,
          "y": 0.4374
        },
        {
          "x": 0.3687,
          "y": 0.4374
        }
      ],
      "id": 22,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='23' data-category='paragraph' style='font-size:16px'>일반적으로 거부반응은 나타나는 시기에 따라 이식한 지 수 분에서 수 일내 발생하는 초급성 거부반응과 6개월 이내에 주로 발생하는 급성 거부반응, 그리고<br>수개월에서 수년이 지난 후 발생하는 만성 거부반응으로 나눌 수 있습니다. 하지만, 급성 거부반응도 6개월 이후에 나타날 수 있고, 만성 거부반응도 보다 이른<br>시간에 생길 수도 있습니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3689,
          "y": 0.4453
        },
        {
          "x": 0.7512,
          "y": 0.4453
        },
        {
          "x": 0.7512,
          "y": 0.4768
        },
        {
          "x": 0.3689,
          "y": 0.4768
        }
      ],
      "id": 23,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='24' data-category='paragraph' style='font-size:16px'>거부반응의 정확한 분류는 앞에서 설명한 발생 시기에 따른 것이 아니고, 이식한 조직에 어떤 세포가 작용하여 어떤 면역기전(면역과정)으로 어떤 조직 변화를<br>일으켰는지에 따라 결정됩니다. 따라서, 거부반응의 기전(과정)과 상태에 따라 초급성, 급성, 만성 거부반응으로 분류하면서, T세포매개성 거부반응과 항체<br>매개성 거부반응으로 다시 세분할 수 있습니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3676,
          "y": 0.482
        },
        {
          "x": 0.7533,
          "y": 0.482
        },
        {
          "x": 0.7533,
          "y": 0.5138
        },
        {
          "x": 0.3676,
          "y": 0.5138
        }
      ],
      "id": 24,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='25' data-category='paragraph' style='font-size:16px'>1) 초급성 거부반응</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3684,
          "y": 0.5327
        },
        {
          "x": 0.4168,
          "y": 0.5327
        },
        {
          "x": 0.4168,
          "y": 0.5437
        },
        {
          "x": 0.3684,
          "y": 0.5437
        }
      ],
      "id": 25,
      "page": 2
    },
    {
      "category": "list",
      "content": {
        "html": "<br><p id='26' data-category='list' style='font-size:16px'>수혜자의 몸속에 기증자의 항원에 대한 항체가 이미 형성되어 있었던 경우 수혜자의 항체가 이식된 장기를 공격하여 발생하는 거부반응입니다. 매우 빠르게<br>진행하고 특별한 치료제가 없기 때문에 이식된 장기를 절제해야 하는 경우가 대부분입니다. 초급성 거부반응은 모두 항체 매개성 거부반응을 보입니다.<br>2) 급성 거부반응<br>이식 장기의 항원을 수혜자의 면역세포가 인지하면서 공격함으로써 발생하는 거부반응입니다. 급성 T세포매개성 거부반응과 급성 항체 매개성 거부반응으로<br>세분할 수 있고, 다양한 면역억제제를 사용하여 예방하거나 치료하기도 합니다.<br>3) 만성 거부반응</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3662,
          "y": 0.5448
        },
        {
          "x": 0.7527,
          "y": 0.5448
        },
        {
          "x": 0.7527,
          "y": 0.6215
        },
        {
          "x": 0.3662,
          "y": 0.6215
        }
      ],
      "id": 26,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='27' data-category='paragraph' style='font-size:16px'>반복적인 급성 거부반응 등 면역학적 원인과 허혈손상, 고혈압, 고혈당, 고지혈증 등 비면역학적 원인에 의해 이식된 장기가 서서히 망가지는 것을 의미합니다.<br>역시 만성 T세포매개성 거부반응과 만성 항체 매개성 거부반응으로 세분할 수 있습니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3678,
          "y": 0.6301
        },
        {
          "x": 0.7516,
          "y": 0.6301
        },
        {
          "x": 0.7516,
          "y": 0.6518
        },
        {
          "x": 0.3678,
          "y": 0.6518
        }
      ],
      "id": 27,
      "page": 2
    },
    {
      "base64_encoding": "/9j/2wCEAAIBAQEBAQIBAQECAgICAgQDAgICAgUEBAMEBgUGBgYFBgYGBwkIBgcJBwYGCAsICQoKCgoKBggLDAsKDAkKCgoBAgICAgICBQMDBQoHBgcKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCv/AABEIATYCbQMBIgACEQEDEQH/xAGiAAABBQEBAQEBAQAAAAAAAAAAAQIDBAUGBwgJCgsQAAIBAwMCBAMFBQQEAAABfQECAwAEEQUSITFBBhNRYQcicRQygZGhCCNCscEVUtHwJDNicoIJChYXGBkaJSYnKCkqNDU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6g4SFhoeIiYqSk5SVlpeYmZqio6Slpqeoqaqys7S1tre4ubrCw8TFxsfIycrS09TV1tfY2drh4uPk5ebn6Onq8fLz9PX29/j5+gEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoLEQACAQIEBAMEBwUEBAABAncAAQIDEQQFITEGEkFRB2FxEyIygQgUQpGhscEJIzNS8BVictEKFiQ04SXxFxgZGiYnKCkqNTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqCg4SFhoeIiYqSk5SVlpeYmZqio6Slpqeoqaqys7S1tre4ubrCw8TFxsfIycrS09TV1tfY2dri4+Tl5ufo6ery8/T19vf4+fr/2gAMAwEAAhEDEQA/APiAft3ftv5P/GZPxW/8OHqf/wAfo/4bt/bf/wCjyfit/wCHD1P/AOP15VgZzRRdhZHqv/Ddv7b/AP0eT8Vv/Dh6n/8AH6P+G7f23/8Ao8n4rf8Ahw9T/wDj9eVUU7sVkeq/8N2/tv8A/R5PxW/8OHqf/wAfo/4bt/bf/wCjyfit/wCHD1P/AOP15VRRdhZHqv8Aw3b+2/8A9Hk/Fb/w4ep//H6P+G7f23/+jyfit/4cPU//AI/XlVFF2Fkeq/8ADdv7b/8A0eT8Vv8Aw4ep/wDx+j/hu39t/wD6PJ+K3/hw9T/+P15VRRdhZHqv/Ddv7b//AEeT8Vv/AA4ep/8Ax+j/AIbt/bf/AOjyfit/4cPU/wD4/XlVFF2Fkeq/8N2/tv8A/R5PxW/8OHqf/wAfo/4bt/bf/wCjyfit/wCHD1P/AOP15VRRdhZHqv8Aw3b+2/8A9Hk/Fb/w4ep//H6P+G7f23/+jyfit/4cPU//AI/XlVFF2Fkeq/8ADdv7b/8A0eT8Vv8Aw4ep/wDx+j/hu39t/wD6PJ+K3/hw9T/+P15VRRdhZHqv/Ddv7b//AEeT8Vv/AA4ep/8Ax+j/AIbt/bf/AOjyfit/4cPU/wD4/XlVFF2Fkeq/8N2/tv8A/R5PxW/8OHqf/wAfo/4bt/bf/wCjyfit/wCHD1P/AOP15VRRdhZHqv8Aw3b+2/nP/DZPxW/8OHqf/wAfo/4bt/bf/wCjyfit/wCHD1P/AOP15VRRcLI9V/4bt/bf/wCjyfit/wCHD1P/AOP0f8N2/tv/APR5PxW/8OHqf/x+vKqKLsLI9V/4bt/bf/6PJ+K3/hw9T/8Aj9H/AA3b+2//ANHk/Fb/AMOHqf8A8fryqii7CyPVf+G7f23/APo8n4rf+HD1P/4/R/w3b+2//wBHk/Fb/wAOHqf/AMfryqii7CyPVf8Ahu39t/8A6PJ+K3/hw9T/APj9H/Ddv7b/AP0eT8Vv/Dh6n/8AH68qoouwsj1X/hu39t//AKPJ+K3/AIcPU/8A4/R/w3b+2/8A9Hk/Fb/w4ep//H68qooux2R6r/w3b+2//wBHk/Fb/wAOHqf/AMfo/wCG7f23/wDo8n4rf+HD1P8A+P15VRRdisj1X/hu39t//o8n4rf+HD1P/wCP0f8ADdv7b/8A0eT8Vv8Aw4ep/wDx+vKqKLsLI9V/4bt/bf8A+jyfit/4cPU//j9H/Ddv7b//AEeT8Vv/AA4ep/8Ax+vKqKLsLI9V/wCG7f23/wDo8n4rf+HD1P8A+P0f8N2/tv8A/R5PxW/8OHqf/wAfryqii7CyPVf+G7f23/8Ao8n4rf8Ahw9T/wDj9H/Ddv7b/wD0eT8Vv/Dh6n/8fryqii7CyPVf+G7f23/+jyfit/4cPU//AI/R/wAN2/tv/wDR5PxW/wDDh6n/APH68qoouwsj1X/hu39t/wD6PJ+K3/hw9T/+P0f8N2/tv/8AR5PxW/8ADh6n/wDH68qoouwsj1X/AIbt/bf/AOjyfit/4cPU/wD4/R/w3b+2/wD9Hk/Fb/w4ep//AB+vKqKLsLI9V/4bt/bf/wCjyfit/wCHD1P/AOP0f8N2/tv/APR5PxW/8OHqf/x+vKqKLsLI9V/4bt/bf/6PJ+K3/hw9T/8Aj9H/AA3b+2//ANHk/Fb/AMOHqf8A8fryqii7CyPVf+G7f23/APo8n4rf+HD1P/4/R/w3b+2//wBHk/Fb/wAOHqf/AMfryqii7CyPVf8Ahu39t/8A6PJ+K3/hw9T/APj9H/Ddv7b/AP0eT8Vv/Dh6n/8AH68qoouwsj1X/hu39t//AKPJ+K3/AIcPU/8A4/R/w3b+2/8A9Hk/Fb/w4ep//H68qoouwsj1X/hu39t//o8n4rf+HD1P/wCP0f8ADdv7b/8A0eT8Vv8Aw4ep/wDx+vKqKLsLI9V/4bt/bf8A+jyfit/4cPU//j9H/Ddv7b//AEeT8Vv/AA4ep/8Ax+vKqKLsLI9V/wCG7f23/wDo8n4rf+HD1P8A+P0f8N2/tv8A/R5PxW/8OHqf/wAfryqii7HZHqv/AA3b+2//ANHk/Fb/AMOHqf8A8fo/4bt/bf8A+jyfit/4cPU//j9eVUUXYrI9V/4bt/bf/wCjyfit/wCHD1P/AOP0f8N2/tv/APR5PxW/8OHqf/x+vKqKLsLI9V/4bt/bf/6PJ+K3/hw9T/8Aj9H/AA3b+2//ANHk/Fb/AMOHqf8A8fryqii7CyPVf+G7f23/APo8n4rf+HD1P/4/R/w3b+2//wBHk/Fb/wAOHqf/AMfryqii7CyPVf8Ahu39t/8A6PJ+K3/hw9T/APj9H/Ddv7b/AP0eT8Vv/Dh6n/8AH68qooux2R6r/wAN2/twZ/5PK+K3/hw9S/8Aj9B/bs/bePX9sj4qn/uoepf/AB+vKSTkClppu4rIKKKKkYUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAIfvClpD94UtNbiCiiikMKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAEP3hS0YGc0U1uAUUUUgCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAoooprcAooopAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRSEnIFLTW4BRRRSAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAEP3hS0h+8KWmtxBRRRSGFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFACH7wpaQ/eFLTW4gooopDCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigBD94UtIfvClprcQUUUUhhRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAh+8KWkP3hS01uIKKKKQwooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAQ/eFLSH7wpaa3EFFFFIYUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAIfvClpD94UtNbiCiiikMKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAEP3hS0h+8KWmtxASuetJkeopmKKQx+R6ijI9RTKKAH5HqKMj1FMooAfkeooyPUUyigB+R6ijI9RTKKAH5HqKMj1FMooAfkeooyPUUyigB+R6ijI9RTKKAH5HqKMj1FMooAfkeooyPUUyigB+R6ijI9RTKKAH5HqKMj1FMooAfkeooyPUUyigB+R6ijI9RTKKAH5HqKMj1FMooAfkeooyPUUyigB+R6ijI9RTKKAH5HqKMj1FMooAfkeooyPUUyigB+R6ijI9RTKKAH5HqKMj1FMooAfkeooyPUUyigB+R6ijI9RTKKAH5HqKMj1FMooAfkeooyPUUyigB+R6ijI9RTKKAH5HqKMj1FMooAfkeooyPUUyigB+R6ijI9RTKKAH5HqKMj1FMooAfkeooyPUUyigB+R6ijI9RTKKAH5HqKMj1FMooAfkeooyPUUyigB+R6ijI9RTKKAH5HqKMj1FMooAfkeooyPUUyigB+R6ijI9RTKKAHEjcORS5HqKjP3hS01uIjEhx96jzD/eFQeYf71J5h/vCkMseYf7wo8w/3hVfzD/eFHmH+8KALHmH+8KPMP8AeFV/MP8AeFHmH+8KALHmH+8KPMP94VX8w/3hR5h/vCgCx5h/vCjzD/eFV/MP94UeYf7woAseYf7wo8w/3hVfzD/eFHmH+8KALHmH+8KPMP8AeFV/MP8AeFHmH+8KALHmH+8KPMP94VX8w/3hR5h/vCgCx5h/vCjzD/eFV/MP94UeYf7woAseYf7wo8w/3hVfzD/eFHmH+8KALHmH+8KPMP8AeFV/MP8AeFHmH+8KALHmH+8KPMP94VX8w/3hR5h/vCgCx5h/vCjzD/eFV/MP94UeYf7woAseYf7wo8w/3hVfzD/eFHmH+8KALHmH+8KPMP8AeFV/MP8AeFHmH+8KALHmH+8KPMP94VX8w/3hR5h/vCgCx5h/vCjzD/eFV/MP94UeYf7woAseYf7wo8w/3hVfzD/eFHmH+8KALHmH+8KPMP8AeFV/MP8AeFHmH+8KALHmH+8KPMP94VX8w/3hR5h/vCgCx5h/vCjzD/eFV/MP94UeYf7woAseYf7wo8w/3hVfzD/eFHmH+8KALHmH+8KPMP8AeFV/MP8AeFHmH+8KALHmH+8KPMP94VX8w/3hR5h/vCgCx5h/vCjzD/eFV/MP94UeYf7woAseYf7wo8w/3hVfzD/eFHmH+8KALHmH+8KPMP8AeFV/MP8AeFHmH+8KALHmH+8KPMP94VX8w/3hR5h/vCgCx5h/vCjzD/eFV/MP94UeYf7woAseYf7wo8w/3hVfzD/eFHmH+8KALHmH+8KPMP8AeFV/MP8AeFHmH+8KALHmH+8KPMP94VX8w/3hR5h/vCgCx5h/vCjzD/eFV/MP94UeYf7woAseYf7wo8w/3hVfzD/eFHmH+8KALHmH+8KPMP8AeFV/MP8AeFHmH+8KALHmH+8KPMP94VX8w/3hR5h/vCgCx5h/vCjzD/eFV/MP94UeYf7woAseYf7wo8w/3hVfzD/eFHmH+8KAJzIdw+YUplx/FVYyHcPmFL5h/vCmtxFfzj05pPOPvVA3Y3EHP50fa196Qy/5x96POPvVD7WvvR9rX3oAv+cfejzj71Q+1r70fa196AL/AJx96POPvVD7WvvR9rX3oAv+cfejzj71Q+1r70fa196AL/nH3o84+9UPta+9H2tfegC/5x96POPvVD7WvvR9rX3oAv8AnH3o84+9UPta+9H2tfegC/5x96POPvVD7WvvR9rX3oAv+cfejzj71Q+1r70fa196AL/nH3o84+9UPta+9H2tfegC/wCcfejzj71Q+1r70fa196AL/nH3o84+9UPta+9H2tfegC/5x96POPvVD7WvvR9rX3oAv+cfejzj71Q+1r70fa196AL/AJx96POPvVD7WvvR9rX3oAv+cfejzj71Q+1r70fa196AL/nH3o84+9UPta+9H2tfegC/5x96POPvVD7WvvR9rX3oAv8AnH3o84+9UPta+9H2tfegC/5x96POPvVD7WvvR9rX3oAv+cfejzj71Q+1r70fa196AL/nH3o84+9UPta+9H2tfegC/wCcfejzj71Q+1r70fa196AL/nH3o84+9UPta+9H2tfegC/5x96POPvVD7WvvR9rX3oAv+cfejzj71Q+1r70fa196AL/AJx96POPvVD7WvvR9rX3oAv+cfejzj71Q+1r70fa196AL/nH3o84+9UPta+9H2tfegC/5x96POPvVD7WvvR9rX3oAv8AnH3o84+9UPta+9H2tfegC/5x96POPvVD7WvvR9rX3oAv+cfejzj71Q+1r70fa196AL/nH3o84+9UPta+9H2tfegC/wCcfejzj71Q+1r70fa196AL/nH3o84+9UPta+9H2tfegC/5x96POPvVD7WvvR9rX3oAvGY7h1pwlJ71nG7XcOtOF2vr+dNbiMwXXJI70v2s1kfbwONx9uaPt4/vGkM1/tZo+1msg34xneaX7eB/H29aANb7WaPtZrI+3j+8aX7eueWP0BoA1vtZo+1msj7euPvnp1Bz/n/61L9tGcbj+Xb/AD+vbrQBrfazR9rNZP24H7rE59OT6/jxQb9RyXwO/tz6/lQBrfazR9rNZP271JHrmk+3j+8aANf7WaPtZrI+3j+8aPt4/vGgDX+1mj7WayPt4/vGj7eP7xoA1/tZo+1msj7eP7xo+3j+8aANf7WaPtZrI+3j+8aPt4/vGgDX+1mj7WayPt4/vGj7eP7xoA1/tZo+1msj7eP7xo+3j+8aANf7WaPtZrI+3j+8aPt4/vGgDX+1mj7WayPt4/vGj7eP7xoA1/tZo+1msj7eP7xo+3j+8aANf7WaPtZrI+3j+8aPt4/vGgDX+1mj7WayPt4/vGj7eP7xoA1/tZo+1msj7eP7xo+3j+8aANf7WaPtZrI+3j+8aPt4/vGgDX+1mj7WayPt4/vGj7eP7xoA1/tZo+1msj7eP7xo+3j+8aANf7WaPtZrI+3j+8aPt4/vGgDX+1mj7WayPt4/vGj7eP7xoA1/tZo+1msj7eP7xo+3j+8aANf7WaPtZrI+3j+8aPt4/vGgDX+1mj7WayPt4/vGj7eP7xoA1/tZo+1msj7eP7xo+3j+8aANf7WaPtZrI+3j+8aPt4/vGgDX+1mj7WayPt4/vGj7eP7xoA1/tZo+1msj7eP7xo+3j+8aANf7WaPtZrI+3j+8aPt6jkvj1yaANf7WaPtZqjPBqltp8eqXOnXEdtM7JFcvA6xuy/eUMRgkd+ePT1rfbxnG48e9AGv9rNH2s1kfbx/eNH28f3jQBr/azR9rNZH28f3jSi/UnG/8zQBrfazR9rNZP24YOGPTuf16UG/XJwx6+v8A9agDW+1mj7WayPt4/vGj7eP7xoA1/tZo+1msj7eP7xo+3jOAxyen1oA1/tZo+1msxJ5nhe6SJ2iiIEkgU7Uz0ycYGaZ9vGPvexwaANU3Z3Cg3mP/ANdZBvxuHzGl+3r3Oaa3EY328/3h7Ufbz/eFY39oZNH9oe36Uhnvv7I3hHwt8RJ/Emg+LdKiu4DZQMhbh4m3t8yMOUPTkH86yvj78A7j4Psmtab4ggutLupSsEc0qpcoeuNvHmAZGWUd+QOtcZ8IPjzqvwbi1e40HS4Z73UYIo4Jrg/JBtZiX2jlzg8DIHc9MHmvE3jnxF4z1eTXvFOrzX13KMNNMckD+6OwX0AAHtQBa+3sDguM/Wj7cx4Dde46+uP0rF/tDtj9KDfkg4HbjjvQB97eGvi1q37L3hD9lTwL8LfCHhq90j4l+Hl8R/EO31XwvZ3/APwlM9x4o1TS3sLmSeF2a3jtNPhiSFSAjyySACR99eW6v8HfgFb/ALeF5+yLHo+pxWqftFN4ai8Qf28v2ePw+NUay8ryfJ3ebjD+f523C42c7hwfwe/4KA/HL4L+DND8F6BY+FdVHhDUp9Q8Ban4m8KW2oXvha6lcSvLYyzI3l/vVWYRuHiSUGVEWRmZvOZPjb8TJvDEvg2XxxqDadN4i/4SCW3a4JZ9T2GMXZY/OZNrEb85zz70Afbnjn4n6h+0JeftW/Bj4i+CfDWn+Hfht4cvtZ+Hml6b4Ys7JvCU9h4k06whtreWGJJFie2u5beVGLea7JI+6VVeu18Vappv/DdXjH/gm8/hTw7H8JNJ+Fus2WmaUvhuyWW3msPCM+pQ64t0IvP+2Pd263T3G8l0leIkxNsHxt8Yf+Cgvx2+NXhLX/C3iay8LWE/jOe3n8f67oPhW2stS8VSwSCaNr+aNAZf36pO4QIssyJLIHkRWV+p/wDBRL9oDVvAM/g+7Tw1/at34STwpfeOU8M2w8QXWiLEsA0973bvZPs6JbGTHnNAvktIYiUoA8sN+c43D6elJ9vP94Vjf2gemOnp/nij+0Pb9KANn7ef7wo+3n+8Kxv7Q9v0o/tD2/SgDZ+3n+8KPt5/vCsb+0Pb9KP7Q9v0oA2ft5/vCj7ef7wrG/tD2/Sj+0Pb9KANn7ef7wo+3n+8Kxv7Q9v0o/tD2/SgDZ+3n+8KPt5/vCsb+0Pb9KP7Q9v0oA2ft5/vCj7ef7wrG/tD2/Sj+0Pb9KANn7ef7wo+3n+8Kxv7Q9v0o/tD2/SgDZ+3n+8KPt5/vCsb+0Pb9KP7Q9v0oA2ft5/vCj7ef7wrG/tD2/Sj+0Pb9KANn7ef7wo+3n+8Kxv7Q9v0o/tD2/SgDZ+3n+8KPt5/vCsb+0Pb9KP7Q9v0oA2ft5/vCj7ef7wrG/tD2/Sj+0Pb9KANn7ef7wo+3n+8Kxv7Q9v0o/tD2/SgDZ+3n+8KPt5/vCsb+0Pb9KP7Q9v0oA2ft5/vCj7ef7wrG/tD2/Sj+0Pb9KANn7ef7wo+3n+8Kxv7Q9v0o/tD2/SgDZ+3n+8KPt5/vCsb+0Pb9KP7Q9v0oA2ft5/vCj7ef7wrG/tD2/Sj+0Pb9KANn7ef7wo+3n+8Kxv7Q9v0o/tD2/SgDZ+3n+8KPt5/vCsb+0Pb9KP7Q9v0oA2ft5/vCj7ef7wrG/tD2/Sj+0Pb9KANn7ef7wo+3n+8Kxv7Q9v0o/tD2/SgDZ+3n+8KPt5/vCsb+0Pb9KP7Q9v0oA2ft5/vCj7ef7wrG/tD2/Sj+0Pb9KANn7e3ZhX0x8FP2W/C9vFo3xD8Ray2prcafDdx6bJbBY0kdFcbvmO8LnpgA45z0r5O/tD2/Su7+GH7SfxE+HWuWt0/iC+1HTYUWGXSry8d4vJGAAgYkRkYGCOmAMEEigD1jQ7e5ttUj0/VtTe90Dxf4t1DS9Q0afGIJvNYR3EOfuMCQSw9B6gDwzU9+lalcaY06ubadojIvRtpIyPy6e9dhpnxn8K+HvtfjmDUb7UNaGoX0vh3R5bfZb6WZ5CTcOc4klIOQo6Y6nCkeYPqTSyNLI5ZmbJYnOffP+f1oA2Pt5/vCj7ef7wrG/tD2/Sj+0Pb9KANn7ef7wrq/hj8VX+HUOs3Npb776+09YLCdreOVYJBIrFisgIPygjoevSvO/7Q9v0rrPhb8Q/CfhaLWtN8ZaJeXtnq+nC2ZbGVEkTEivuBYED7uM/40AbHgT4zeIfCHjZ/FkssUqX18suswixhb7RGZN8iKrKQmQWA24xnt2w/FXiODXPFGpa3ZwmKG8v5poY2ABRHcsAcccA4qXwH40+GvhjxzJ4k1nQtVubSzvludGghuYwybJNyeaSMOMBQcY5zWF4s8TQ+IPFWp69bWxhivdQmnjhbqgdywU47gECgCz9vP94Ufbz/AHhWN/aHt+lH9oe36UAbP28/3hSi/OfvjnjHrWL/AGh7fpQdQx/T3NAHsfge8+In/DPPil9F1DRl0JLyP+0Ibn/j6Lfux+7P3QD8g+br823kEHzY35z/AKwH3zV/w/4g+FcPw01ix8QaRfyeJJbhG0i6hlKwxR/LncNwXPD5yCcMMYrlvt5x0/n1oA2DfncPmFDahjqwrGOofMOP0oOoDvTW4jJF97j2zQb4DqwrKa7wMgnFN+1jOCx/D/65pDNY6goGNwpP7RX1psHhPxncwrcW/hHVJI3XckkenylWB5BB28jGKd/whvjn/oTNX/8ABbL/APE0AH9oj1FH9ornPFH/AAhvjn/oTNX/APBbL/8AE0f8Ib45/wChM1f/AMFsv/xNAB/aK4xkY9DS/wBpDGN3Gc/jSf8ACG+Of+hM1f8A8Fsv/wATR/whvjn/AKEzV/8AwWy//E0AH9orjbxj0pf7SyMFv1pP+EN8c/8AQmav/wCC2X/4mj/hDfHP/Qmav/4LZf8A4mgA/tFQMDGPQUf2iPUUf8Ib45/6EzV//BbL/wDE0f8ACG+Of+hM1f8A8Fsv/wATQAf2iPUUf2iPUUf8Ib45/wChM1f/AMFsv/xNH/CG+Of+hM1f/wAFsv8A8TQAf2iPUUf2iPUUf8Ib45/6EzV//BbL/wDE0f8ACG+Of+hM1f8A8Fsv/wATQAf2iPUUf2iPUUf8Ib45/wChM1f/AMFsv/xNH/CG+Of+hM1f/wAFsv8A8TQAf2iPUUf2iPUUf8Ib45/6EzV//BbL/wDE0f8ACG+Of+hM1f8A8Fsv/wATQAf2iPUUf2iPUUf8Ib45/wChM1f/AMFsv/xNH/CG+Of+hM1f/wAFsv8A8TQAf2iPUUf2iPUUf8Ib45/6EzV//BbL/wDE0f8ACG+Of+hM1f8A8Fsv/wATQAf2iPUUf2iPUUf8Ib45/wChM1f/AMFsv/xNH/CG+Of+hM1f/wAFsv8A8TQAf2iPUUf2iPUUf8Ib45/6EzV//BbL/wDE0f8ACG+Of+hM1f8A8Fsv/wATQAf2iPUUf2iPUUf8Ib45/wChM1f/AMFsv/xNH/CG+Of+hM1f/wAFsv8A8TQAf2iPUUf2iPUUf8Ib45/6EzV//BbL/wDE0f8ACG+Of+hM1f8A8Fsv/wATQAf2iPUUf2iPUUf8Ib45/wChM1f/AMFsv/xNH/CG+Of+hM1f/wAFsv8A8TQAf2iPUUf2iPUUf8Ib45/6EzV//BbL/wDE0f8ACG+Of+hM1f8A8Fsv/wATQAf2iPUUf2iPUUf8Ib45/wChM1f/AMFsv/xNH/CG+Of+hM1f/wAFsv8A8TQAf2iPUUf2iPUUf8Ib45/6EzV//BbL/wDE0f8ACG+Of+hM1f8A8Fsv/wATQAf2iPUUf2iPUUf8Ib45/wChM1f/AMFsv/xNH/CG+Of+hM1f/wAFsv8A8TQAf2iPUUf2iPUUf8Ib45/6EzV//BbL/wDE0f8ACG+Of+hM1f8A8Fsv/wATQAf2iPUUf2iPUUf8Ib45/wChM1f/AMFsv/xNH/CG+Of+hM1f/wAFsv8A8TQAf2iPUUf2iPUUf8Ib45/6EzV//BbL/wDE0f8ACG+Of+hM1f8A8Fsv/wATQAf2iPUUf2iPUUf8Ib45/wChM1f/AMFsv/xNH/CG+Of+hM1f/wAFsv8A8TQAf2iPUUf2iPUUf8Ib45/6EzV//BbL/wDE0f8ACG+Of+hM1f8A8Fsv/wATQAf2iPUUf2iPUUf8Ib45/wChM1f/AMFsv/xNH/CG+Of+hM1f/wAFsv8A8TQAf2iPUUf2iPUUf8Ib45/6EzV//BbL/wDE0f8ACG+Of+hM1f8A8Fsv/wATQAf2iPUUf2iPUUf8Ib45/wChM1f/AMFsv/xNH/CG+Of+hM1f/wAFsv8A8TQAf2iPUUf2iPUUf8Ib45/6EzV//BbL/wDE0f8ACG+Of+hM1f8A8Fsv/wATQAf2iPUUf2iPUUf8Ib45/wChM1f/AMFsv/xNH/CG+Of+hM1f/wAFsv8A8TQAf2iPXp0o/tEeoo/4Q3xz/wBCZq//AILZf/iaP+EN8c/9CZq//gtl/wDiaAD+0R6ij+0R6ij/AIQ3xz/0Jmr/APgtl/8AiaP+EN8c/wDQmav/AOC2X/4mgA/tEeopf7RHrSf8Ib45/wChM1f/AMFsv/xNH/CG+Of+hM1f/wAFsv8A8TQAv9pDGMjHpSf2ivrR/wAIb45/6EzV/wDwWy//ABNH/CG+Of8AoTNX/wDBbL/8TQAf2iPUUf2iPUUf8Ib45/6EzV//AAWy/wDxNH/CG+Of+hM1f/wWy/8AxNAB/aI9RR/aK+oo/wCEN8c/9CZq/wD4LZf/AImj/hDfHP8A0Jmr/wDgtl/+JoAUaguc7hn1oF+ueCv5Uh8G+OR18G6v/wCC2X/4mqmqaZrehlV1rR7uz3g7PtVs8e7HXG4DJ6fnQBbN9lhhhThej+Jh+FZK3YDAHIPoaf8Aa17jNNbiM57nC4B/DNLaalJZ3Ud3HsLROHAkGVJBzgg9R6iqZkBGDim+YwyBSGfSMX/BRHxYEVZvhxpzSBQJGW8cZP0waX/h4l4p/wCibaf/AOBz/wDxNfNvmNSbz6CgD6T/AOHiXin/AKJtp/8A4HP/APE0f8PEvFP/AETbT/8AwOf/AOJr5s3n0FG8+goA+k/+HiXin/om2n/+Bz//ABNH/DxLxT/0TbT/APwOf/4mvmzefQUbz6CgD6T/AOHiXin/AKJtp/8A4HP/APE0f8PEvFP/AETbT/8AwOf/AOJr5s3n0FG8+goA+k/+HiXin/om2n/+Bz//ABNH/DxLxT/0TbT/APwOf/4mvmzefQUbz6CgD6T/AOHiXin/AKJtp/8A4HP/APE0f8PEvFP/AETbT/8AwOf/AOJr5s3n0FG8+goA+k/+HiXin/om2n/+Bz//ABNH/DxLxT/0TbT/APwOf/4mvmzefQUbz6CgD6T/AOHiXin/AKJtp/8A4HP/APE0f8PEvFP/AETbT/8AwOf/AOJr5s3n0FG8+goA+k/+HiXin/om2n/+Bz//ABNH/DxLxT/0TbT/APwOf/4mvmzefQUbz6CgD6T/AOHiXin/AKJtp/8A4HP/APE0f8PEvFP/AETbT/8AwOf/AOJr5s3n0FG8+goA+k/+HiXin/om2n/+Bz//ABNH/DxLxT/0TbT/APwOf/4mvmzefQUbz6CgD6T/AOHiXin/AKJtp/8A4HP/APE0f8PEvFP/AETbT/8AwOf/AOJr5s3n0FG8+goA+k/+HiXin/om2n/+Bz//ABNH/DxLxT/0TbT/APwOf/4mvmzefQUbz6CgD6T/AOHiXin/AKJtp/8A4HP/APE0f8PEvFP/AETbT/8AwOf/AOJr5s3n0FG8+goA+k/+HiXin/om2n/+Bz//ABNH/DxLxT/0TbT/APwOf/4mvmzefQUbz6CgD6T/AOHiXin/AKJtp/8A4HP/APE0f8PEvFP/AETbT/8AwOf/AOJr5s3n0FG8+goA+k/+HiXin/om2n/+Bz//ABNH/DxLxT/0TbT/APwOf/4mvmzefQUbz6CgD6T/AOHiXin/AKJtp/8A4HP/APE0f8PEvFP/AETbT/8AwOf/AOJr5s3n0FG8+goA+k/+HiXin/om2n/+Bz//ABNH/DxLxT/0TbT/APwOf/4mvmzefQUbz6CgD6T/AOHiXin/AKJtp/8A4HP/APE0f8PEvFP/AETbT/8AwOf/AOJr5s3n0FG8+goA+k/+HiXin/om2n/+Bz//ABNH/DxLxT/0TbT/APwOf/4mvmzefQUbz6CgD6T/AOHiXin/AKJtp/8A4HP/APE0f8PEvFP/AETbT/8AwOf/AOJr5s3n0FG8+goA+k/+HiXin/om2n/+Bz//ABNH/DxLxT/0TbT/APwOf/4mvmzefQUbz6CgD6T/AOHiXin/AKJtp/8A4HP/APE0f8PEvFP/AETbT/8AwOf/AOJr5s3n0FG8+goA+k/+HiXin/om2n/+Bz//ABNH/DxLxT/0TbT/APwOf/4mvmzefQUbz6CgD6T/AOHiXin/AKJtp/8A4HP/APE0f8PEvFP/AETbT/8AwOf/AOJr5s3n0FG8+goA+k/+HiXin/om2n/+Bz//ABNH/DxLxT/0TbT/APwOf/4mvmzefQUbz6CgD6T/AOHiXin/AKJtp/8A4HP/APE0f8PEvFP/AETbT/8AwOf/AOJr5s3n0FG8+goA+k/+HiXin/om2n/+Bz//ABNH/DxLxT/0TbT/APwOf/4mvmzefQUbz6CgD6T/AOHiXin/AKJtp/8A4HP/APE0f8PEvFP/AETbT/8AwOf/AOJr5s3n0FG8+goA+k/+HiXin/om2n/+Bz//ABNH/DxLxT/0TbT/APwOf/4mvmzefQUbz6CgD6T/AOHiXin/AKJtp/8A4HP/APE0f8PEvFP/AETbT/8AwOf/AOJr5s3n0FG8+goA+k/+HiXin/om2n/+Bz//ABNH/DxLxT/0TbT/APwOf/4mvmzefQUbz6CgD6T/AOHiXin/AKJtp/8A4HP/APE0f8PEvFP/AETbT/8AwOf/AOJr5s3n0FG8+goA+k/+HiXin/om2n/+Bz//ABNH/DxLxT/0TbT/APwOf/4mvmzefQUbz6CgD6T/AOHiXin/AKJtp/8A4HP/APE0f8PEvFP/AETbT/8AwOf/AOJr5s3n0FG8+goA+kz/AMFEvFIH/JNtP/8AA5/8K4f46ftTa/8AHDQrTw9f+FbHT4bW7+0eZBIzu7bGUDccYGGYkd8D0ryTefQUByOgH5UAWxc4dcE4z1/z/nmpDdkdxVJW5ycU4yKeuPzprcCNlwob1pKc3+qX/eP8hTaQBRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUo2/xA/hSUU1uB/9k=",
      "category": "figure",
      "content": {
        "html": "<figure id='28'><img style='font-size:14px' alt=\"0:00\" data-coord=\"top-left:(1372,1574); bottom-right:(1993,1884)\" /></figure>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.4576,
          "y": 0.6716
        },
        {
          "x": 0.6644,
          "y": 0.6716
        },
        {
          "x": 0.6644,
          "y": 0.8039
        },
        {
          "x": 0.4576,
          "y": 0.8039
        }
      ],
      "id": 28,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='29' data-category='paragraph' style='font-size:20px'>개요-원인</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3687,
          "y": 0.8215
        },
        {
          "x": 0.4046,
          "y": 0.8215
        },
        {
          "x": 0.4046,
          "y": 0.8353
        },
        {
          "x": 0.3687,
          "y": 0.8353
        }
      ],
      "id": 29,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='30' data-category='paragraph' style='font-size:16px'>1) 조직적합성 항원에 대한 면역반응</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3695,
          "y": 0.8423
        },
        {
          "x": 0.4572,
          "y": 0.8423
        },
        {
          "x": 0.4572,
          "y": 0.8536
        },
        {
          "x": 0.3695,
          "y": 0.8536
        }
      ],
      "id": 30,
      "page": 2
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='31' data-category='paragraph' style='font-size:16px'>거부반응은 수혜자의 몸 안에서 기증자의 장기가 가지고 있는 항원이 '남의 것'으로 인식되어 생기는데, '조직적합성 항원'이 가장 대표적인 거부반응을 일으키는<br>항원입니다. 조직적합성 항원은 인간 염색체 6번에 존재하는 인간 백혈구 항원(Human leukocyte antigen, HLA)입니다. 수혜자와 기증자 사이에 HLA 항원이<br>일치하는 숫자가 많을수록 급성 거부반응이 적은데, 현재에는 면역억제제가 강력해져 HLA 항원의 일치도가 갖는 중요성은 과거보다는 줄어들었습니다. 수혜자의<br>혈액 내에 기증자의 HLA 항원에 반응하는 항체의 양이 이식 전부터 많을 때 초급성 거부반응을 일으킬 수 있기 때문에, 이식 전에 수혜자의 항체를 충분히<br>제거해야 합니다. 또는 HLA 항원에 대한 항체가 이식 전에는 없다가 이식 후 생성되어 급성이나 만성 항체 매개성 거부반응을 일으킬 수 있습니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3669,
          "y": 0.8549
        },
        {
          "x": 0.754,
          "y": 0.8549
        },
        {
          "x": 0.754,
          "y": 0.9115
        },
        {
          "x": 0.3669,
          "y": 0.9115
        }
      ],
      "id": 31,
      "page": 2
    },
    {
      "base64_encoding": "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",
      "category": "figure",
      "content": {
        "html": "<figure id='32'><img alt=\"\" data-coord=\"top-left:(1419,88); bottom-right:(1962,469)\" /></figure>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.4731,
          "y": 0.0379
        },
        {
          "x": 0.6542,
          "y": 0.0379
        },
        {
          "x": 0.6542,
          "y": 0.2002
        },
        {
          "x": 0.4731,
          "y": 0.2002
        }
      ],
      "id": 32,
      "page": 3
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='33' data-category='paragraph' style='font-size:14px'>2) 혈액형 항원에 대한 면역반응</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3691,
          "y": 0.2196
        },
        {
          "x": 0.4466,
          "y": 0.2196
        },
        {
          "x": 0.4466,
          "y": 0.2301
        },
        {
          "x": 0.3691,
          "y": 0.2301
        }
      ],
      "id": 33,
      "page": 3
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='34' data-category='paragraph' style='font-size:14px'>적혈구 표면에 존재하는 혈액형 항원(ABO 항원)이 이식 장기 내의 혈관세포에도 존재하기 때문에 수혈 이상반응과 마찬가지로, 장기이식 거부반응을 일으킬 수<br>있습니다. 혈액형 부적합 이식의 경우, 이식 전에 항 혈액형 항체가 많이 존재하면 초급성 거부반응이 나타날 수 있습니다. 따라서 이식 전에 항체를 충분히<br>제거한 후 이식을 해야 하고, 이식 후 초기 4주 내에도 항체 수를 낮게 유지해야 급성 항체 매개성 거부반응을 예방할 수 있습니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3676,
          "y": 0.2348
        },
        {
          "x": 0.7547,
          "y": 0.2348
        },
        {
          "x": 0.7547,
          "y": 0.2684
        },
        {
          "x": 0.3676,
          "y": 0.2684
        }
      ],
      "id": 34,
      "page": 3
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='35' data-category='paragraph' style='font-size:18px'>진단 및 검사</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.368,
          "y": 0.2842
        },
        {
          "x": 0.4141,
          "y": 0.2842
        },
        {
          "x": 0.4141,
          "y": 0.2983
        },
        {
          "x": 0.368,
          "y": 0.2983
        }
      ],
      "id": 35,
      "page": 3
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='36' data-category='paragraph' style='font-size:14px'>1. 장기이식 전 검사</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3687,
          "y": 0.3051
        },
        {
          "x": 0.4177,
          "y": 0.3051
        },
        {
          "x": 0.4177,
          "y": 0.3157
        },
        {
          "x": 0.3687,
          "y": 0.3157
        }
      ],
      "id": 36,
      "page": 3
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='37' data-category='paragraph' style='font-size:14px'>1) 조직적합성 항원 및 항체 검사</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3696,
          "y": 0.3204
        },
        {
          "x": 0.4481,
          "y": 0.3204
        },
        {
          "x": 0.4481,
          "y": 0.3315
        },
        {
          "x": 0.3696,
          "y": 0.3315
        }
      ],
      "id": 37,
      "page": 3
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='38' data-category='paragraph' style='font-size:14px'>장기이식 후 거부반응을 방지하고 합병증을 예방하기 위해서 장기이식 전에 수혜자와 기증자의 조직적합성 항원을 검사해야 합니다. HLA 검사에는 HLA 항원형<br>(HLA 항원 종류)을 검사하는 것과 기증자와 수혜자 사이의 HLA 교차검사가 있습니다. HLA 항원검사 결과 수혜자와 기증자 사이에 항원이 일치하는 숫자가<br>많을수록 급성 거부반응이 적고, 이식한 장기의 생존율이 향상됩니다. 만약 가능한 기증자가 한 명뿐일 경우에는 일치하는 HLA 숫자가 적은 경우에라도 어느<br>정도의 좋은 결과를 기대할 수 있기 때문에 장기이식을 진행할 수 있습니다. HLA 교차검사는 수혜자의 혈액 내에 기증자의 HLA 항원에 반응하는 항체의 유무와<br>강도를 검사하는 것입니다. 더욱 정밀한 조직적합성 항원 및 항체 검사가 개발되어 이식 전에 초급성 거부반응의 발생 가능성을 미리 제거하고, 급성 항체 매개성<br>거부반응을 예방하는데 도움을 주고 있습니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3673,
          "y": 0.3367
        },
        {
          "x": 0.7524,
          "y": 0.3367
        },
        {
          "x": 0.7524,
          "y": 0.3995
        },
        {
          "x": 0.3673,
          "y": 0.3995
        }
      ],
      "id": 38,
      "page": 3
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='39' data-category='paragraph' style='font-size:14px'>2) 혈액형 항원 및 항체 검사</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3689,
          "y": 0.4042
        },
        {
          "x": 0.4375,
          "y": 0.4042
        },
        {
          "x": 0.4375,
          "y": 0.4155
        },
        {
          "x": 0.3689,
          "y": 0.4155
        }
      ],
      "id": 39,
      "page": 3
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='40' data-category='paragraph' style='font-size:14px'>혈액형 항원(ABO 항원) 및 항 혈액형 항체 검사를 시행하여 이식 후 발생할 수 있는 초급성 거부반응을 예방하고, 항원 불일치로 인한 심각한 거부반응이나<br>합병증을 줄여야 합니다. ABO 혈액형 검사를 통해 동일한 혈액형 사이에 이식할 때는 문제가 없고, 동일하지 않더라도 수혈이 가능한 혈액형, 예를 들어 O형이<br>A형이나 B형의 수혜자에게 기증 시에는 장기이식이 가능합니다. 기증자의 혈액형이 수혈이 불가능한 부적합 혈액형일 경우에는 이식 후 초급성 거부반응이<br>일어나게 됩니다. 그러나, 최근에는 혈액형이 부적합한 경우, 항 혈액형 항체 자체와 이 항체를 생산하는 면역세포(B세포)를 제거하는 탈감작 치료를 통해<br>성공적인 장기이식이 가능하게 되었습니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3665,
          "y": 0.4203
        },
        {
          "x": 0.7535,
          "y": 0.4203
        },
        {
          "x": 0.7535,
          "y": 0.4729
        },
        {
          "x": 0.3665,
          "y": 0.4729
        }
      ],
      "id": 40,
      "page": 3
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='41' data-category='paragraph' style='font-size:14px'>2. 거부반응 진단</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3683,
          "y": 0.4916
        },
        {
          "x": 0.411,
          "y": 0.4916
        },
        {
          "x": 0.411,
          "y": 0.5022
        },
        {
          "x": 0.3683,
          "y": 0.5022
        }
      ],
      "id": 41,
      "page": 3
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='42' data-category='paragraph' style='font-size:14px'>거부반응은 임상적인 소견이나 검사 소견을 통해 의심할 수 있으나, 확진은 이식한 장기에 대한 조직검사에 의해 이루어집니다. 장기이식 후에 발생한 거부반응은<br>즉각 알아차리기 힘든 경우가 많습니다. 이는 거부반응이 역반응에 의해 서서히 진행되며, 최근 사용되는 강력한 면역억제제가 거부반응의 증상을 가리기<br>때문입니다. 즉, 장기를 이식한 부위의 자연 통증 또는 눌러서 생기는 압통 같이 과거에 나타났던 전형적인 거부반응의 증상이나 징후는 최근 면역억제제의 효능<br>때문에 뚜렷이 나타나지 않는 경우가 대부분입니다. 따라서, 정기적인 관찰과 검사가 중요합니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.366,
          "y": 0.5069
        },
        {
          "x": 0.7535,
          "y": 0.5069
        },
        {
          "x": 0.7535,
          "y": 0.5504
        },
        {
          "x": 0.366,
          "y": 0.5504
        }
      ],
      "id": 42,
      "page": 3
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='43' data-category='paragraph' style='font-size:14px'>급성 거부반응은 일반적으로 이식 후 6개월 이내, 특히 3개월 이내에 발생하는 것이 대부분이므로 이 기간 동안에는 특히 주의해서 관찰해야 합니다. 신장이식의<br>거부반응으로는 잘 나오던 소변의 양이 줄면서 몸무게가 늘어나고, 혈압이 상승하며, 신장기능을 반영하는 혈청 크레아티닌 수치가 지난 검사보다 높아질 수<br>있습니다. 그러나, 환자들이 판단하기에 이런 변화가 초기에는 미미할 수 있어, 급성 거부반응이 점점 진행되다가 나중에 심해진 이후 발견되는 경우도 많습니다.<br>따라서, 임상 소견만으로는 거부반응을 진단할 수는 없고, 어느 정도 의심이 될 경우에는 이식된 장기에 대한 조직검사를 실시해서 이식된 장기의 조직 손상 상태,<br>공격하고 있는 면역세포의 종류와 침윤 정도 등으로 거부반응과 그 종류를 진단합니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.367,
          "y": 0.5551
        },
        {
          "x": 0.7526,
          "y": 0.5551
        },
        {
          "x": 0.7526,
          "y": 0.606
        },
        {
          "x": 0.367,
          "y": 0.606
        }
      ],
      "id": 43,
      "page": 3
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='44' data-category='paragraph' style='font-size:14px'>거부반응과 구별해야 하는 질환으로는 면역억제제 과다투여나 다른 약제에 의한 독성 장기손상, 말기장기부전을 일으켰던 원질환(기저질환) 재발, 바이러스 감염<br>등이 있습니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3673,
          "y": 0.6119
        },
        {
          "x": 0.7518,
          "y": 0.6119
        },
        {
          "x": 0.7518,
          "y": 0.6336
        },
        {
          "x": 0.3673,
          "y": 0.6336
        }
      ],
      "id": 44,
      "page": 3
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='45' data-category='paragraph' style='font-size:18px'>치료</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3689,
          "y": 0.6508
        },
        {
          "x": 0.3865,
          "y": 0.6508
        },
        {
          "x": 0.3865,
          "y": 0.6645
        },
        {
          "x": 0.3689,
          "y": 0.6645
        }
      ],
      "id": 45,
      "page": 3
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='46' data-category='paragraph' style='font-size:14px'>1. 면역억제 치료</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3699,
          "y": 0.6722
        },
        {
          "x": 0.4112,
          "y": 0.6722
        },
        {
          "x": 0.4112,
          "y": 0.6821
        },
        {
          "x": 0.3699,
          "y": 0.6821
        }
      ],
      "id": 46,
      "page": 3
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='47' data-category='paragraph' style='font-size:14px'>1) 면역억제 치료의 중요성</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3692,
          "y": 0.6872
        },
        {
          "x": 0.4339,
          "y": 0.6872
        },
        {
          "x": 0.4339,
          "y": 0.6957
        },
        {
          "x": 0.3692,
          "y": 0.6957
        }
      ],
      "id": 47,
      "page": 3
    },
    {
      "category": "list",
      "content": {
        "html": "<br><p id='48' data-category='list' style='font-size:14px'>면역억제제를 복용하는 경우 가장 중요한 점은 '얼마나 약물치료를 잘 지키는가' 입니다. 이에 따라 이식한 장기의 생존율이 좌우됩니다. 이식 후 초기 약물치료를<br>잘 따르던 환자가 1~2년 지나면서 약을 한두 번 먹지 않아도 별 증상에 변화가 없는 것을 경험하면 병원에 오는 것을 스스로 중단하거나 규칙적인 약물 복용을 잘<br>지키지 못하는 경우를 볼 수 있습니다. 그러나 스스로 약물치료를 중단하거나 불규칙하게 약물을 복용하면 이식 장기에 손상이 일어나고, 결국에 장기를 재이식을<br>해야 하거나 사망에 이르는 결과가 이어질 수 있습니다. 거부반응은 이식 후 언제라도 나타날 수 있기 때문에 이를 예방하기 위해서는 현재로선 평생<br>면역억제제를 복용해야 하며, 규칙적으로 약을 복용하는 것이 중요합니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3678,
          "y": 0.702
        },
        {
          "x": 0.7531,
          "y": 0.702
        },
        {
          "x": 0.7531,
          "y": 0.755
        },
        {
          "x": 0.3678,
          "y": 0.755
        }
      ],
      "id": 48,
      "page": 3
    },
    {
      "category": "list",
      "content": {
        "html": "<br><p id='49' data-category='list' style='font-size:14px'>2) 거부반응 예방을 위한 유도 및 유지 면역억제 치료<br>이식 환자들은 거부반응을 억제하기 위해 이식 직후에는 유도 면역억제 치료와 장기간의 유지 면역억제 치료를 받습니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3688,
          "y": 0.7595
        },
        {
          "x": 0.6541,
          "y": 0.7595
        },
        {
          "x": 0.6541,
          "y": 0.7868
        },
        {
          "x": 0.3688,
          "y": 0.7868
        }
      ],
      "id": 49,
      "page": 3
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='50' data-category='paragraph' style='font-size:14px'>3) 거부반응 치료를 위한 항거부반응 면역억제 치료</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3692,
          "y": 0.7903
        },
        {
          "x": 0.4921,
          "y": 0.7903
        },
        {
          "x": 0.4921,
          "y": 0.7988
        },
        {
          "x": 0.3692,
          "y": 0.7988
        }
      ],
      "id": 50,
      "page": 3
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='51' data-category='paragraph' style='font-size:14px'>유지 면역억제 치료에도 불구하고 거부반응이 발생하거나, 환자가 약을 제대로 복용하지 않아 거부반응이 생긴 경우, 이를 회복시키기 위해서 추가적으로<br>강력하게 투여하는 면역억제제 치료를 항거부반응 면역억제 치료라고 합니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3683,
          "y": 0.8047
        },
        {
          "x": 0.7528,
          "y": 0.8047
        },
        {
          "x": 0.7528,
          "y": 0.8272
        },
        {
          "x": 0.3683,
          "y": 0.8272
        }
      ],
      "id": 51,
      "page": 3
    },
    {
      "category": "list",
      "content": {
        "html": "<p id='52' data-category='list' style='font-size:14px'>2. 거부반응의 예방을 위한 면역억제 치료<br>1) 유도 면역억제 치료<br>장기이식 직후 입원 기간 중, 거부반응을 억제하기 위해 바실릭시맙(시뮬렉트) 또는 다클론 항림프구 항체인 티모글로불린(에이티지) 주사제를 투여 받습니다.<br>2) 유지 면역억제 치료<br>거부반응의 발생을 예방하기 위해 2~4가지의 면역억제제를 함께 사용하여 이식 후부터 평생 동안 복용합니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3659,
          "y": 0.8452
        },
        {
          "x": 0.7459,
          "y": 0.8452
        },
        {
          "x": 0.7459,
          "y": 0.9187
        },
        {
          "x": 0.3659,
          "y": 0.9187
        }
      ],
      "id": 52,
      "page": 3
    },
    {
      "category": "list",
      "content": {
        "html": "<p id='53' data-category='list' style='font-size:14px'>3. 거부반응의 치료<br>1) 초급성 거부반응에 대한 치료<br>초급성 거부반응은 일단 발생하면 치료가 거의 불가능하기 때문에, 기증자와 수혜자 간의 항원 교차반응 검사 등으로 예방하는 것이 필수입니다.<br>2) 급성 거부반응에 대한 치료</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3666,
          "y": 0.9366
        },
        {
          "x": 0.7117,
          "y": 0.9366
        },
        {
          "x": 0.7117,
          "y": 0.9933
        },
        {
          "x": 0.3666,
          "y": 0.9933
        }
      ],
      "id": 53,
      "page": 3
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='54' data-category='paragraph' style='font-size:14px'>급성 거부반응 중, 급성 T세포매개성 거부반응은 급성 항체 매개성 거부반응보다 치료 반응률이 높습니다. 급성 T세포매개성 거부반응은 고용량 스테로이드<br>충격요법을 일차적으로 사용하고 반응이 없을 경우 다클론 항림프구 항체(예를 들어 티모글로불린, 에이티지(antithymocyte globulin, ATG))를 2차 치료제로<br>사용하여 치료하는데, 1차치료에 약 75%, 2차치료에 60%가 반응하여 총 약 90%의 반응률을 보입니다. 그래도 반응이 없을 경우, 유지 면역억제제를 더 강한<br>약제로 바꾸어서 치료해 보기도 합니다. 예를 들어, 사이클로스포린에서 타크로리무스로 바꾸거나, 사용하고 있지 않다면 마이코페놀레이트 계열의 약제를<br>추가하기도 합니다. 급성 항체매개성 거부반응은 T세포매개성 거부반응보다 치료 반응률이 낮은데, 혈장반출술, 리툭시맙, 보르테조밉, 고용량 면역글로불린<br>주사 등의 치료를 시도해 볼 수 있습니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3673,
          "y": 0
        },
        {
          "x": 0.7538,
          "y": 0
        },
        {
          "x": 0.7538,
          "y": 0.0677
        },
        {
          "x": 0.3673,
          "y": 0.0677
        }
      ],
      "id": 54,
      "page": 4
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='55' data-category='paragraph' style='font-size:14px'>3) 만성 거부반응에 대한 치료</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3684,
          "y": 0.0674
        },
        {
          "x": 0.4413,
          "y": 0.0674
        },
        {
          "x": 0.4413,
          "y": 0.0789
        },
        {
          "x": 0.3684,
          "y": 0.0789
        }
      ],
      "id": 55,
      "page": 4
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='56' data-category='paragraph' style='font-size:14px'>만성 거부반응은 면역억제제를 거르거나 정확하게 복용하지 않은 경우가 중요한 원인이며, 치료에 의한 반응률이 낮습니다. 만성 거부반응에 대한 면역억제<br>치료는 기본적으로 급성 거부반응에 대한 면역억제 치료와 유사합니다. 만성 거부반응에 대한 치료에서 조직 장기의 만성 변화가 심할수록 치료 반응률이 낮기<br>때문에 만성적 섬유화 진행이 초기일 경우에는 강한 면역억제 치료도 고려하나, 만성적 섬유화 진행이 심하게 진행된 경우에는 지나치게 강한 면역억제는 치료<br>효능보다 부작용이 더 문제가 될 수 있습니다. 만성 거부반응에는 면역학적 원인 이외에도 고혈압, 고지혈증, 고혈당, 약물 독성 다양한 비면역학적 원인들도<br>기여하기 때문에 이에 대한 효과적인 조절도 중요합니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3671,
          "y": 0.0829
        },
        {
          "x": 0.754,
          "y": 0.0829
        },
        {
          "x": 0.754,
          "y": 0.1368
        },
        {
          "x": 0.3671,
          "y": 0.1368
        }
      ],
      "id": 56,
      "page": 4
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='57' data-category='paragraph' style='font-size:18px'>치료-약물 치료</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3685,
          "y": 0.1539
        },
        {
          "x": 0.4225,
          "y": 0.1539
        },
        {
          "x": 0.4225,
          "y": 0.167
        },
        {
          "x": 0.3685,
          "y": 0.167
        }
      ],
      "id": 57,
      "page": 4
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='58' data-category='paragraph' style='font-size:14px'>1. 면역억제제의 종류</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3696,
          "y": 0.1742
        },
        {
          "x": 0.4217,
          "y": 0.1742
        },
        {
          "x": 0.4217,
          "y": 0.1846
        },
        {
          "x": 0.3696,
          "y": 0.1846
        }
      ],
      "id": 58,
      "page": 4
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='59' data-category='paragraph' style='font-size:14px'>1) 유도 면역억제제</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3692,
          "y": 0.1899
        },
        {
          "x": 0.4163,
          "y": 0.1899
        },
        {
          "x": 0.4163,
          "y": 0.1985
        },
        {
          "x": 0.3692,
          "y": 0.1985
        }
      ],
      "id": 59,
      "page": 4
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='60' data-category='paragraph' style='font-size:14px'>① 항흉선세포글로불린, 에이티지(티모글로불린)</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3684,
          "y": 0.2049
        },
        {
          "x": 0.4848,
          "y": 0.2049
        },
        {
          "x": 0.4848,
          "y": 0.2156
        },
        {
          "x": 0.3684,
          "y": 0.2156
        }
      ],
      "id": 60,
      "page": 4
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='61' data-category='paragraph' style='font-size:14px'>다클론성 항림프구 항체의 하나로서 현재 토끼에 인간 흉선 T세포를 면역하여 만들어집니다. 장기 재이식 환자나 고감작 환자 등 거부반응의 위험이 높은<br>환자들에게 수술 직후 3-5일간 주사하는 강력한 유도 치료로서 급성 거부반응을 예방합니다. 임파종이나 바이러스 감염 등 부작용의 위험이 있기 때문에<br>저위험군 환자에서는 일반적으로 사용하지 않으나 저용량으로 사용해 볼 수도 있습니다. 또한, 세포성 거부반응이 스테로이드 충격요법에 반응이 없을 경우,<br>항거부반응 치료에서 2차 약제로 5-14일간 사용해 볼 수 있습니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3671,
          "y": 0.2199
        },
        {
          "x": 0.7533,
          "y": 0.2199
        },
        {
          "x": 0.7533,
          "y": 0.2636
        },
        {
          "x": 0.3671,
          "y": 0.2636
        }
      ],
      "id": 61,
      "page": 4
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='62' data-category='paragraph' style='font-size:14px'>② 바실릭시맙(시뮬렉트)</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3684,
          "y": 0.2674
        },
        {
          "x": 0.4288,
          "y": 0.2674
        },
        {
          "x": 0.4288,
          "y": 0.2771
        },
        {
          "x": 0.3684,
          "y": 0.2771
        }
      ],
      "id": 62,
      "page": 4
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='63' data-category='paragraph' style='font-size:14px'>이식 당일과 이식 후 4일째 주사하는 유도 면역억제제 치료제로서, 거부반응의 위험이 높지 않은 경우에 거부반응 예방 목적으로 사용합니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3679,
          "y": 0.2816
        },
        {
          "x": 0.7021,
          "y": 0.2816
        },
        {
          "x": 0.7021,
          "y": 0.2932
        },
        {
          "x": 0.3679,
          "y": 0.2932
        }
      ],
      "id": 63,
      "page": 4
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='64' data-category='paragraph' style='font-size:14px'>2) 유지 면역억제제</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3685,
          "y": 0.3126
        },
        {
          "x": 0.4168,
          "y": 0.3126
        },
        {
          "x": 0.4168,
          "y": 0.3217
        },
        {
          "x": 0.3685,
          "y": 0.3217
        }
      ],
      "id": 64,
      "page": 4
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='65' data-category='paragraph' style='font-size:14px'>① 스테로이드 (프레드니솔론, 소론도, 캘코트, 프란딘)</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3689,
          "y": 0.3269
        },
        {
          "x": 0.4995,
          "y": 0.3269
        },
        {
          "x": 0.4995,
          "y": 0.3381
        },
        {
          "x": 0.3689,
          "y": 0.3381
        }
      ],
      "id": 65,
      "page": 4
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='66' data-category='paragraph' style='font-size:14px'>1960년대 이후 가장 오랫동안 사용되어온 면역억제제로서 급성 거부반응 치료와 면역억제 유지 요법에 광범위하게 사용되고 있습니다. 그러나, 여러가지<br>부작용이 동반되는데, 대표적인 부작용으로 속쓰림, 혈압 상승, 혈당 상승, 여드름과 피부 발적(피부가 빨간빛을 띠는 것), 부종, 골다공증 및 대퇴골 괴사증 등이<br>있습니다. 이식 후 단기간에 대량의 스테로이드가 투여되어 당뇨병, 골다공증, 소아에서 성장장애 등이 발생할 수 있으며, 약물 용량에 비례하여 다양한 부작용이<br>발생합니다. 스테로이드 치료의 심한 부작용이 발생할 경우 용량을 줄이거나 중단할 수 있는데, 이 경우 거부반응의 위험이 올라간다는 잠재적인 문제점도<br>있습니다. 특히, 거부반응의 위험이 높은 이식 환자의 경우 스테로이드를 줄이거나 중단할 경우 급성 거부반응의 위험이 높아지기 때문에, 담당의사와 충분한<br>상의 후에 스테로이드 용량 조절을 하는 것이 바람직합니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3678,
          "y": 0.3421
        },
        {
          "x": 0.7537,
          "y": 0.3421
        },
        {
          "x": 0.7537,
          "y": 0.407
        },
        {
          "x": 0.3678,
          "y": 0.407
        }
      ],
      "id": 66,
      "page": 4
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='67' data-category='paragraph' style='font-size:14px'>② 칼시뉴린 억제제 계열의 약물</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3683,
          "y": 0.426
        },
        {
          "x": 0.4471,
          "y": 0.426
        },
        {
          "x": 0.4471,
          "y": 0.4376
        },
        {
          "x": 0.3683,
          "y": 0.4376
        }
      ],
      "id": 67,
      "page": 4
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='68' data-category='paragraph' style='font-size:14px'>• 사이클로스포린(산디문뉴오랄, 사이폴-엔)</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3702,
          "y": 0.4408
        },
        {
          "x": 0.4784,
          "y": 0.4408
        },
        {
          "x": 0.4784,
          "y": 0.4519
        },
        {
          "x": 0.3702,
          "y": 0.4519
        }
      ],
      "id": 68,
      "page": 4
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='69' data-category='paragraph' style='font-size:14px'>1980년대 초부터 신장이식에 사용된 사이클로스포린은 강력한 면역억제제로 이식 후의 거부반응을 예방하기 위해 사용합니다. 사이클로스포린은 식사와<br>관계없이 12시간 간격으로 일정하게 하루에 두 번 복용합니다. 경구용 캡슐제의 용량은 100 mg과 25 mg의 2가지 용량이 있으므로 처방받은 약의 용량을<br>정확히 알고 복용해야 합니다. 시럽제를 복용할 때는 우유, 오렌지 주스와 같은 음료에 섞어서 복용할 수 있으며, 자몽주스는 이 약의 흡수에 영향을 끼치므로<br>피하거나 4시간 이상 간격을 두어야 합니다. 시럽을 음료수와 함께 유리컵에 넣고 금속으로 된 숟가락으로 저어 섞은 다음 바로 마시고, 한번 더 음료수를 넣고<br>유리컵을 흔들어 준 후 마십니다. 이 때 플라스틱 용기를 사용하면 약효가 떨어지므로 사용하지 않도록 합니다. 대표적인 부작용으로는 신장기능 저하, 혈압상승,<br>두통, 고지혈증, 구토, 다모증, 잇몸 증식, 혈당상승, 감염, 열감 등이 있습니다. 용량과 비례해서 부작용이 늘어나기 때문에 반드시 약물 복용 직전의 최저<br>약물농도를 측정해 가면서 목표 농도 내에서 사용하는 것이 중요합니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3678,
          "y": 0.456
        },
        {
          "x": 0.7536,
          "y": 0.456
        },
        {
          "x": 0.7536,
          "y": 0.5313
        },
        {
          "x": 0.3678,
          "y": 0.5313
        }
      ],
      "id": 69,
      "page": 4
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='70' data-category='paragraph' style='font-size:14px'>• 타크로리무스(프로그랍, 타크로벨, 아드바그랍)</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3701,
          "y": 0.5351
        },
        {
          "x": 0.4891,
          "y": 0.5351
        },
        {
          "x": 0.4891,
          "y": 0.5465
        },
        {
          "x": 0.3701,
          "y": 0.5465
        }
      ],
      "id": 70,
      "page": 4
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='71' data-category='paragraph' style='font-size:14px'>타크로리무스는 사이클로스포린과 유사하게 작용하여 장기이식 후 거부반응을 억제하는 목적으로 사용하는 약으로, 사이클로스포린의 10~100배의 효능을<br>가진다고 알려져 있습니다. 음식과 함께 복용할 경우 약물의 흡수에 방해가 되므로, 반드시 공복(배 속이 비어 있는 상태) 상태에서 복용해야 합니다. 12시간<br>간격으로 하루 2번, 복용 시간은 식사하기 1시간 전 또는 식사 후 2시간이 좋습니다. 최근에는 12시간 간격으로 먹던 프로그라프를 하루 1회 복용으로<br>약물농도를 유지할 수 있는 '아드바그랍' 이라는 서방형 약제(체내에서 천천히 효과가 방출되는 약제)를 사용할 수 있습니다. 대표적인 부작용으로는 신장기능<br>저하, 혈압 상승, 혈당 상승, 손떨림, 탈모 등이 있습니다. 초기 고용량 투여 때 구토, 두통, 손떨림 등이 나타날 수 있으나 점차 감소되며, 긴 기간 동안 복용할 경우<br>탈모가 나타날 수 있습니다. 사이클로스포린과 유사한 부작용을 보이나 특별히 신경독성, 당뇨병, 탈모증이 더 많이 생기는 것으로 알려져 있습니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3674,
          "y": 0.5495
        },
        {
          "x": 0.753,
          "y": 0.5495
        },
        {
          "x": 0.753,
          "y": 0.6147
        },
        {
          "x": 0.3674,
          "y": 0.6147
        }
      ],
      "id": 71,
      "page": 4
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='72' data-category='paragraph' style='font-size:14px'>③ 마이코페놀릭산(셀셉트, 마이렙트, 마이폴틱)</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3687,
          "y": 0.6337
        },
        {
          "x": 0.4845,
          "y": 0.6337
        },
        {
          "x": 0.4845,
          "y": 0.6448
        },
        {
          "x": 0.3687,
          "y": 0.6448
        }
      ],
      "id": 72,
      "page": 4
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='73' data-category='paragraph' style='font-size:14px'>마이코페놀릭산은 단독으로 사용되기보다는 다른 면역억제제에 추가하여 사용됩니다. 마이코페놀릭산을 추가하여 같이 투여할 경우, 다른 면역억제제를 적게<br>사용해도 같은 효과를 볼 수 있어 면역억제제로 인한 신장 독성을 줄일 수 있습니다. 비슷한 계열의 약제인 아자치오프린이 모든 세포에 비선택적으로 작용하는데<br>반해 마이코페노릭산은 선택적이라는 장점이 있습니다. 하루 2번 아침, 저녁으로 복용하며, 캡슐과 장용정(위산에 강한 성분을 넣어 장에서 소화되게 하는 약제)<br>2가지 제형이 있습니다. 장용정의 경우 용량에 따라 약의 모양이 다르므로 처방받은 약의 용량을 정확히 알고 복용해야 합니다. 마이코페놀릭산은 빈 속에<br>복용하는 것이 약물 흡수를 위해 권장되지만, 위장장애가 있는 경우에는 식사 후에 복용할 수 있습니다. 부작용으로 설사, 구토, 식욕부진과 같은 위장 장애가<br>흔하며, 빈혈, 백혈구감소증, 혈소판감소증과 같은 골수 억제 효과가 나타날 수 있습니다. 그리고 바이러스 감염을 증가시킵니다. 최근에 셀셉트의 위장장애를<br>개선하기 위해 장내에서 흡수되도록 만든 마이폴틱이 시중에 판매되어 사용되고 있습니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3673,
          "y": 0.6493
        },
        {
          "x": 0.7537,
          "y": 0.6493
        },
        {
          "x": 0.7537,
          "y": 0.7237
        },
        {
          "x": 0.3673,
          "y": 0.7237
        }
      ],
      "id": 73,
      "page": 4
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='74' data-category='paragraph' style='font-size:14px'>④ 엠토르 억제제: 시롤리무스(라파뮨), 에베로리무스(써티칸)</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3687,
          "y": 0.7429
        },
        {
          "x": 0.5161,
          "y": 0.7429
        },
        {
          "x": 0.5161,
          "y": 0.7539
        },
        {
          "x": 0.3687,
          "y": 0.7539
        }
      ],
      "id": 74,
      "page": 4
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='75' data-category='paragraph' style='font-size:14px'>이 계열의 면역억제제들은 타크로리무스와 같은 칼시뉴린 억제제보다 종양 발생이 적은 것으로 알려져 있어 종양의 병력이 있던 환자에서 예방적으로 쓰거나,<br>이식 후 발생한 종양에서 치료적으로도 사용할 수 있습니다. 시롤리무스는 1일 1회, 에베로리무스는 1일 2회 복용합니다. 식사와 관계없이 일정 시간에 복용이<br>가능하고, 시롤리무스는 사이클로스포린과 함께 사용하는 경우 사이클로스포린을 복용하고 4시간이 지난 이후에 복용합니다. 자몽이나 자몽 주스와 함께<br>복용하는 것은 금하며, 다음 약 복용하기 직전 최저 혈액 내 약물 농도를 측정하여 약물용량을 조절합니다. 대표적인 부작용으로 감염 위험이 증가하는 것과<br>고지혈증, 고혈압 발생이 증가할 수 있습니다. 칼시뉴린 억제제보다는 덜하지만 당뇨병과 신독성도 나타날 수 있습니다. 또한 수술초기 상처치유가 늦어지는<br>부작용이 나타날 수 있습니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3679,
          "y": 0.7591
        },
        {
          "x": 0.7533,
          "y": 0.7591
        },
        {
          "x": 0.7533,
          "y": 0.8218
        },
        {
          "x": 0.3679,
          "y": 0.8218
        }
      ],
      "id": 75,
      "page": 4
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='76' data-category='paragraph' style='font-size:14px'>⑤ 기타 약제: 미조리빈(브레디닌), 아자치오프린(이뮤란)</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3689,
          "y": 0.8416
        },
        {
          "x": 0.5065,
          "y": 0.8416
        },
        {
          "x": 0.5065,
          "y": 0.8526
        },
        {
          "x": 0.3689,
          "y": 0.8526
        }
      ],
      "id": 76,
      "page": 4
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='77' data-category='paragraph' style='font-size:14px'>미조리빈은 마이코페놀릭산 계열의 약제와 유사한 효능을 가지고 있고, 하루 100 ml를 두 번 복용하나 신장 기능이 감소될 경우 용량을 줄여야 합니다.<br>아자치오프린은 주로 다른 면역억제제에 추가하여 사용되는데, 하루에 1번 아침 또는 저녁 식사 후 30분에 복용합니다. 골수 억제작용 때문에 백혈구 숫자가<br>감소하고 빈혈이나 혈소판 감소도 함께 나타납니다. 그 외에도 위장장애와 간염에 의한 황달과 같은 부작용이 나타날 수 있습니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.368,
          "y": 0.8556
        },
        {
          "x": 0.754,
          "y": 0.8556
        },
        {
          "x": 0.754,
          "y": 0.8887
        },
        {
          "x": 0.368,
          "y": 0.8887
        }
      ],
      "id": 77,
      "page": 4
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='78' data-category='paragraph' style='font-size:14px'>2. 면역억제제 치료의 원칙</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.368,
          "y": 0.9082
        },
        {
          "x": 0.4338,
          "y": 0.9082
        },
        {
          "x": 0.4338,
          "y": 0.9188
        },
        {
          "x": 0.368,
          "y": 0.9188
        }
      ],
      "id": 78,
      "page": 4
    },
    {
      "category": "list",
      "content": {
        "html": "<br><p id='79' data-category='list' style='font-size:14px'>면역억제제 치료의 원칙은 환자가 효과를 최대로 유지하면서 부작용은 최소화할 수 있는 최적 용량을 유지하는 것으로, 칼시뉴린 억제제나 엠토르 억제제의<br>경우에는 최적 농도를 유지하는 것이 중요합니다.<br>면역억제제 치료에서 유의해야 할 점은, 환자마다 동일한 용량의 면역억제제를 복용하더라도 약물 흡수나 분해가 틀리기 때문에 혈액 내 농도가 틀릴 수 있고,<br>심지어 같은 혈액 내 약물 농도에 대해서도 환자가 보이는 면역억제 효과나 부작용에 대한 민감도가 틀립니다. 따라서 환자 개인마다 약물 농도를 정기적으로<br>확인해야 하고, 환자의 면역억제제에 대한 민감도를 개인별로 평가하는 것이 필요합니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3672,
          "y": 0.922
        },
        {
          "x": 0.7538,
          "y": 0.922
        },
        {
          "x": 0.7538,
          "y": 0.9819
        },
        {
          "x": 0.3672,
          "y": 0.9819
        }
      ],
      "id": 79,
      "page": 4
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='80' data-category='paragraph' style='font-size:16px'>이식 후 면역억제제로 인해 다양한 부작용이 발생할 수 있습니다. 면역억제제는 미생물이나 암에 대한 우리 몸의 면역력을 낮춰 결과적으로 암의 성장을 돕거나<br>감염이 쉽게 발생할 수 있으며, 신장이나 간독성을 나타낼 수도 있습니다. 따라서 이런 면역억제제로 인한 부작용을 줄이기 위해서는 가능한 적은 유지용량으로<br>약물을 복용하도록 조절하는 것이 중요하지만, 너무 적게 먹을 경우 목표 농도보다 낮아져서 거부반응이 발생한다는 문제점도 고려하여 무조건 적은 용량보다는<br>적정한 용량을 복용하는 것이 중요합니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3672,
          "y": 0.0162
        },
        {
          "x": 0.7523,
          "y": 0.0162
        },
        {
          "x": 0.7523,
          "y": 0.0595
        },
        {
          "x": 0.3672,
          "y": 0.0595
        }
      ],
      "id": 80,
      "page": 5
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='81' data-category='paragraph' style='font-size:16px'>일반적으로 이식 후 6개월 정도까지는 초기에 흔히 발생하는 급성 거부반응을 예방하기 위해서 각종 면역억제제를 고용량으로 사용하지만, 이후 서서히 양을<br>줄여 나가게 됩니다. 현재 면역억제 치료는 다른 기전으로 작용하는 2~3가지 다른 면역억제제들을 동시에 사용하는 병용요법이 가장 흔합니다. 이렇게 여러 개의<br>다른 면역억제제를 병용하는 이유는, 첫째, 한 개의 약제만으로는 충분히 모든 면역 과정을 차단시킬 수 없다는 점이고, 둘째, 병용요법을 하면 각각의 약제<br>투여량은 줄어들어서 부작용은 감소하지만, 약의 효과는 증가시킬 수 있기 때문입니다. 과거에는 스테로이드와 아자치오프린(azathioprine) 두 가지 약제를 함께<br>사용하는 2제 병용요법를 했지만, 지금은 칼시뉴린 억제제 계열의 약제들 중 한 개(타크로리무스 또는 사이클로스포린)와 마이코페노릭산(셀셉트, 마이폴틱),<br>그리고 스테로이드를 함께 사용하는 3자 병용요법을 널리 사용하고 있습니다. 또한, 시롤리무스 또는 에베로리무스를 마이코페노릭산 계열의 약제나 칼시뉴린<br>억제제를 대체해서 사용한 3제 요법이 이용되기도 합니다. 이런 기본 면역억제 치료에서, 거부반응이나 약제의 부작용이 발생할 경우, 약제를 교체해 볼 수<br>있습니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3669,
          "y": 0.0653
        },
        {
          "x": 0.7535,
          "y": 0.0653
        },
        {
          "x": 0.7535,
          "y": 0.1504
        },
        {
          "x": 0.3669,
          "y": 0.1504
        }
      ],
      "id": 81,
      "page": 5
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='82' data-category='paragraph' style='font-size:16px'>3. 면역억제제 치료 경과 관찰</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3687,
          "y": 0.1692
        },
        {
          "x": 0.4414,
          "y": 0.1692
        },
        {
          "x": 0.4414,
          "y": 0.1802
        },
        {
          "x": 0.3687,
          "y": 0.1802
        }
      ],
      "id": 82,
      "page": 5
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='83' data-category='paragraph' style='font-size:16px'>장기이식을 받은 경우 면역억제제를 복용하면서 정기적으로 병원을 방문하여 약물의 혈중농도를 측정하기 위해 채혈을 하고, 그 결과에 따라 약물용량 조절을<br>하면서 평생 치료를 지속해야 합니다. 혹시라도 약물치료 중 약물복용을 잊었을 때는 생각났을 때 일단 빨리 약을 복용하지만 한꺼번에 2회 용량을 복용해서는 안<br>된다는 것을 기억해야 합니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3674,
          "y": 0.1831
        },
        {
          "x": 0.753,
          "y": 0.1831
        },
        {
          "x": 0.753,
          "y": 0.2163
        },
        {
          "x": 0.3674,
          "y": 0.2163
        }
      ],
      "id": 83,
      "page": 5
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='84' data-category='paragraph' style='font-size:16px'>한편 면역억제제로 인해 감염에 대한 방어기능이 약화되기 때문에 정상인보다 쉽게 세균이나 바이러스, 곰팡이에 의한 감염이 나타날 수 있습니다. 따라서<br>고열이나 기침, 인후통과 같은 호흡기 감염 증상이나 자주 소변을 보거나 배뇨 시 불편감, 잔뇨감과 같이 감염을 의심할 만한 증상이 나타나면 의료진을 방문하여<br>상의해야 합니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3668,
          "y": 0.2211
        },
        {
          "x": 0.7522,
          "y": 0.2211
        },
        {
          "x": 0.7522,
          "y": 0.2544
        },
        {
          "x": 0.3668,
          "y": 0.2544
        }
      ],
      "id": 84,
      "page": 5
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='85' data-category='paragraph' style='font-size:16px'>그리고 규칙적으로 암, 혈압, 혈당, 고지혈증, 골다공증 등 합병증에 대한 평가를 통해 면역억제제로 인한 부작용 예방 및 조기발견에 노력해야 합니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3676,
          "y": 0.2566
        },
        {
          "x": 0.7229,
          "y": 0.2566
        },
        {
          "x": 0.7229,
          "y": 0.2689
        },
        {
          "x": 0.3676,
          "y": 0.2689
        }
      ],
      "id": 85,
      "page": 5
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='86' data-category='paragraph' style='font-size:22px'>치료-비약물 치료</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3685,
          "y": 0.2851
        },
        {
          "x": 0.43,
          "y": 0.2851
        },
        {
          "x": 0.43,
          "y": 0.2989
        },
        {
          "x": 0.3685,
          "y": 0.2989
        }
      ],
      "id": 86,
      "page": 5
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='87' data-category='paragraph' style='font-size:16px'>만성 거부반응에는 면역학적 기전 이외에도 비면역학적 기전도 존재합니다. 오늘날 생존 기간이 긴 장기이식 환자의 합병증을 줄이기 위해서 약물 치료 이외에<br>생활습관 교정과 관리도 필요합니다. 따라서, 식사와 운동, 생활습관 관리를 통해 고혈압, 고지혈증, 고혈당, 비만을 관리하는 것이 만성 거부반응과 이식 후<br>합병증을 줄이는데 중요합니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3679,
          "y": 0.3055
        },
        {
          "x": 0.7534,
          "y": 0.3055
        },
        {
          "x": 0.7534,
          "y": 0.3384
        },
        {
          "x": 0.3679,
          "y": 0.3384
        }
      ],
      "id": 87,
      "page": 5
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='88' data-category='paragraph' style='font-size:22px'>예방</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3682,
          "y": 0.3548
        },
        {
          "x": 0.3867,
          "y": 0.3548
        },
        {
          "x": 0.3867,
          "y": 0.3689
        },
        {
          "x": 0.3682,
          "y": 0.3689
        }
      ],
      "id": 88,
      "page": 5
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='89' data-category='paragraph' style='font-size:16px'>거부반응을 예방하기 위해서는 이식 전 기증자와 수혜자의 교차 검사를 통해 기증자의 주조직적합성 항원을 공격하는 항체를 피해야 하고, 기증자가 여러 명이<br>있을 경우 수혜자의 주조직적합성 항원과 가장 잘 맞는 사람을 선택하는 것이 좋습니다. 이식 후에는 면역억제제의 최적 농도가 유지될 수 있도록 면역억제제를<br>규칙적이고 정확하게 복용함으로써 적절한 면역억제 상태를 유지하는 것이 거부반응 예방에 가장 중요합니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3671,
          "y": 0.3759
        },
        {
          "x": 0.7528,
          "y": 0.3759
        },
        {
          "x": 0.7528,
          "y": 0.4085
        },
        {
          "x": 0.3671,
          "y": 0.4085
        }
      ],
      "id": 89,
      "page": 5
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='90' data-category='paragraph' style='font-size:22px'>자가 관리</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3684,
          "y": 0.4254
        },
        {
          "x": 0.4033,
          "y": 0.4254
        },
        {
          "x": 0.4033,
          "y": 0.439
        },
        {
          "x": 0.3684,
          "y": 0.439
        }
      ],
      "id": 90,
      "page": 5
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='91' data-category='paragraph' style='font-size:16px'>오늘날 급성 거부반응이 효과적으로 조절되면서 장기이식의 성적은 크게 향상되어 신장이식의 경우 평균적으로 이식된 신장의 기능이 20년 이상 유지되고<br>있습니다. 따라서, 이식 환자가 장기 생존함에 따라 면역억제제의 만성 합병증이나 기저질환으로 인한 만성 합병증을 잘 관리하는 것이 생존 기간 연장과 삶의 질<br>향상에 중요합니다. 암이나 심장병, 당뇨병, 고지혈증, 근골격계 합병증 등 다양한 합병증에 대한 환자 자신의 생활습관 교정과 정기적인 건강검진이 필요합니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3676,
          "y": 0.4462
        },
        {
          "x": 0.7529,
          "y": 0.4462
        },
        {
          "x": 0.7529,
          "y": 0.4802
        },
        {
          "x": 0.3676,
          "y": 0.4802
        }
      ],
      "id": 91,
      "page": 5
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='92' data-category='paragraph' style='font-size:22px'>자주하는 질문</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3681,
          "y": 0.4957
        },
        {
          "x": 0.4192,
          "y": 0.4957
        },
        {
          "x": 0.4192,
          "y": 0.5101
        },
        {
          "x": 0.3681,
          "y": 0.5101
        }
      ],
      "id": 92,
      "page": 5
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='93' data-category='paragraph' style='font-size:20px'>Q. 면역억제제 중 가장 많이 사용하는 사이클로스포린과 병용했을 때 사이클로스포린의 약물농도를 증량하거나 감량하나요?</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3683,
          "y": 0.5221
        },
        {
          "x": 0.7013,
          "y": 0.5221
        },
        {
          "x": 0.7013,
          "y": 0.5354
        },
        {
          "x": 0.3683,
          "y": 0.5354
        }
      ],
      "id": 93,
      "page": 5
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='94' data-category='paragraph' style='font-size:16px'>A.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3692,
          "y": 0.541
        },
        {
          "x": 0.3758,
          "y": 0.541
        },
        {
          "x": 0.3758,
          "y": 0.5495
        },
        {
          "x": 0.3692,
          "y": 0.5495
        }
      ],
      "id": 94,
      "page": 5
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='95' data-category='paragraph' style='font-size:16px'>사이클로스포린의 약물농도를 낮추는 약제 중에는 딜란틴(dilantin), 페노바비탈(phenobarbital), 테그레톨(tegretol), 리팜핌(rifampin) 등이 있고, 높이는<br>약제에는 베라파밀(verapamil), 딜티아젬(diltiazem), 케토코나졸(ketoconazole), 에리스로마이신(erythromycin), 시메타딘(cimetidine), 암포테리신<br>B(amphotericin B) 등이 있습니다. 이들 대부분이 면역억제 치료 중에 사용 가능한 약제이기 때문에 상호작용을 감안해서 약을 증량 또는 감량해서<br>사용해야 합니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3735,
          "y": 0.5553
        },
        {
          "x": 0.7478,
          "y": 0.5553
        },
        {
          "x": 0.7478,
          "y": 0.6002
        },
        {
          "x": 0.3735,
          "y": 0.6002
        }
      ],
      "id": 95,
      "page": 5
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='96' data-category='paragraph' style='font-size:20px'>Q. 장기이식 시, 골수이식을 같이 한다는 말은 무엇을 의미합니까?</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.369,
          "y": 0.6134
        },
        {
          "x": 0.547,
          "y": 0.6134
        },
        {
          "x": 0.547,
          "y": 0.6265
        },
        {
          "x": 0.369,
          "y": 0.6265
        }
      ],
      "id": 96,
      "page": 5
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='97' data-category='paragraph' style='font-size:16px'>A.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3692,
          "y": 0.6326
        },
        {
          "x": 0.3758,
          "y": 0.6326
        },
        {
          "x": 0.3758,
          "y": 0.6411
        },
        {
          "x": 0.3692,
          "y": 0.6411
        }
      ],
      "id": 97,
      "page": 5
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='98' data-category='paragraph' style='font-size:16px'>장기이식을 해서 이식조직의 항원이 몸 속에 들어와도 깨닫지 못하는 수혜자가 있는데 이런 경우는 서로 다른 조직들이 한 몸 속에 공존하며 살아가는<br>것입니다. 이런 상황을 면역치료에 이용하기 위해 장기이식 전에 기증자의 골수를 수혜자에게 이식하여 수혜자 몸 안의 면역세포들이 이후 이식된 장기의<br>항원을 남의 것으로 인식하지 못하게 하는 것입니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3733,
          "y": 0.6472
        },
        {
          "x": 0.7476,
          "y": 0.6472
        },
        {
          "x": 0.7476,
          "y": 0.6804
        },
        {
          "x": 0.3733,
          "y": 0.6804
        }
      ],
      "id": 98,
      "page": 5
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='99' data-category='paragraph' style='font-size:20px'>Q. 향후 면역 치료의 방향은 어떤 것들이 있나요?</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3681,
          "y": 0.695
        },
        {
          "x": 0.5003,
          "y": 0.695
        },
        {
          "x": 0.5003,
          "y": 0.7072
        },
        {
          "x": 0.3681,
          "y": 0.7072
        }
      ],
      "id": 99,
      "page": 5
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='100' data-category='paragraph' style='font-size:16px'>A.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3692,
          "y": 0.7135
        },
        {
          "x": 0.3758,
          "y": 0.7135
        },
        {
          "x": 0.3758,
          "y": 0.722
        },
        {
          "x": 0.3692,
          "y": 0.722
        }
      ],
      "id": 100,
      "page": 5
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='101' data-category='paragraph' style='font-size:16px'>면역치료의 목적은 이식 장기의 항원을 인식하지 못하게 하도록 면역 체계를 억제하는 것입니다. 따라서 이상적으로는 수혜자가 기증조직에 대해 내성을<br>갖게 해주는 면역관용 상태를 만들거나, 외부 이식 항원에 반응을 하지 않도록 해주는 면역 무반응 상태를 만들어 주는 것입니다. 기증자의 항원을<br>반복적으로 수혜자에게 노출시켜서 자기 것인 것처럼 인식하게 해주는 탈감작법, 기증자의 골수세포를 함께 이식해주어 수혜자 체내에 기증자와 수혜자<br>면역세포가 공존하게 하여 기증자의 항원을 인지하지 못하게 하는 방법, 기증자의 T세포를 모두 파괴시키는 방법 등의 이론적인 방법은 가능하고 일부는<br>임상 적용 중에 있습니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.3717,
          "y": 0.7283
        },
        {
          "x": 0.7483,
          "y": 0.7283
        },
        {
          "x": 0.7483,
          "y": 0.7811
        },
        {
          "x": 0.3717,
          "y": 0.7811
        }
      ],
      "id": 101,
      "page": 5
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='102' data-category='paragraph' style='font-size:18px'>본 공공저작물은 공공누리 \"출처표시+상업적이용금지+변경금지\" 조건에 따라 이용할 수 있<br>습니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.5049,
          "y": 0.8122
        },
        {
          "x": 0.7415,
          "y": 0.8122
        },
        {
          "x": 0.7415,
          "y": 0.8361
        },
        {
          "x": 0.5049,
          "y": 0.8361
        }
      ],
      "id": 102,
      "page": 5
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='103' data-category='paragraph' style='font-size:14px'> 목록</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.5531,
          "y": 0.8592
        },
        {
          "x": 0.5684,
          "y": 0.8592
        },
        {
          "x": 0.5684,
          "y": 0.8663
        },
        {
          "x": 0.5531,
          "y": 0.8663
        }
      ],
      "id": 103,
      "page": 5
    },
    {
      "category": "header",
      "content": {
        "html": "<br><header id='104' style='font-size:18px'>개인정보처리방침 개인정보이용안내 저작권정책 및 웹접근성</header>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.264,
          "y": 0
        },
        {
          "x": 0.4362,
          "y": 0
        },
        {
          "x": 0.4362,
          "y": 0.0104
        },
        {
          "x": 0.264,
          "y": 0.0104
        }
      ],
      "id": 104,
      "page": 6
    },
    {
      "category": "list",
      "content": {
        "html": "<p id='105' data-category='list' style='font-size:18px'>[ 28159 ] 충청북도 청주시 흥덕구 오송읍 오송생명2로 187 오송보건의료행정타운 내 질병관리청<br>문의사항: 02-2030-6602 (평일 9:00-17:00, 12:00-13:00 제외) / 관리자 이메일 : nhis@korea.kr</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.2638,
          "y": 0.029
        },
        {
          "x": 0.5074,
          "y": 0.029
        },
        {
          "x": 0.5074,
          "y": 0.0528
        },
        {
          "x": 0.2638,
          "y": 0.0528
        }
      ],
      "id": 105,
      "page": 6
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='106' data-category='paragraph' style='font-size:14px'>COPYRIGHT @ 2024 질병관리청. ALL RIGHT RESERVED</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.2652,
          "y": 0.0526
        },
        {
          "x": 0.3839,
          "y": 0.0526
        },
        {
          "x": 0.3839,
          "y": 0.0597
        },
        {
          "x": 0.2652,
          "y": 0.0597
        }
      ],
      "id": 106,
      "page": 6
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<p id='107' data-category='paragraph' style='font-size:18px'>※ 본 페이지에서 제공하는 내용은 참고사항일 뿐 게시물에 대한 법적책임은 없음을 밝혀드립니다. 자세한 내용은 전문가와 상담하시기 바랍니다.</p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.2655,
          "y": 0.0785
        },
        {
          "x": 0.617,
          "y": 0.0785
        },
        {
          "x": 0.617,
          "y": 0.0913
        },
        {
          "x": 0.2655,
          "y": 0.0913
        }
      ],
      "id": 107,
      "page": 6
    },
    {
      "category": "paragraph",
      "content": {
        "html": "<br><p id='108' data-category='paragraph' style='font-size:18px'>해외기관  유관기관  정부기관 </p>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.5544,
          "y": 0.0335
        },
        {
          "x": 0.7408,
          "y": 0.0335
        },
        {
          "x": 0.7408,
          "y": 0.0422
        },
        {
          "x": 0.5544,
          "y": 0.0422
        }
      ],
      "id": 108,
      "page": 6
    },
    {
      "base64_encoding": "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",
      "category": "figure",
      "content": {
        "html": "<figure id='109'><img alt=\"\" data-coord=\"top-left:(2150,140); bottom-right:(2260,224)\" /></figure>",
        "markdown": "",
        "text": ""
      },
      "coordinates": [
        {
          "x": 0.7168,
          "y": 0.06
        },
        {
          "x": 0.7536,
          "y": 0.06
        },
        {
          "x": 0.7536,
          "y": 0.0956
        },
        {
          "x": 0.7168,
          "y": 0.0956
        }
      ],
      "id": 109,
      "page": 6
    }
  ],
  "merged_elements": [],
  "model": "document-parse-250116",
  "ocr": false,
  "usage": {
    "pages": 6
  }
}